rfhg_89702.1

Basic information about the TSS

---

TSS ID: rfhg_89702.1 Species: human Chr: chr6		Start: 159726996 End: 159726998 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3925431,EH38E2520840)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000650096.1:0 ENST00000614346.4:0 GeneID: 9589 HGNC/MGI_ID: HGNC:16846 UniProt_ID: A0A087X1R4 Q15007 Nearer transcript ids and distances: AK127822:99 NM_001270532.2:119 NM_152858.3:119 NM_004906.5:119 AK290854:119 LF385539:122 MA621116:122 AF374416:122 BC000383:141 BC004432:141 BC069192:164 LF340300:-169 MA575877:-169 BC028180:456 view more...

Gene_name: WT1 associated protein Gene_symbol: WTAP Gene_synonyms: KIAA0105 MGC3925 Mum2 Gene_source: HGNC:16846

TATA-Box annotation

---

Distance to TSS:	-1
Nearest PromoterID:	NM_152858
Entrez ID:	9589
Nearest Unigene:	Hs.446091
Nearest Refseq:	NM_004906
Nearest Ensembl:	ENSG00000146457
Gene Name:	WT1 associated protein
Gene Alias:	Mum2
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.333333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@WTAP p2@WTAP p3@WTAP p4@WTAP p5@WTAP p7@WTAP p9@WTAP p10@WTAP
Sample		p1@WTAP	p2@WTAP	p3@WTAP	p4@WTAP	p5@WTAP	p7@WTAP	p9@WTAP	p10@WTAP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	35.26	89.61	12.86	8.18	0.58	0.19	0.00	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	37.02	86.59	11.33	8.90	0.61	0.81	0.00	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	39.16	90.28	11.57	9.07	0.39	0.96	0.00	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	33.47	77.34	11.44	9.36	0.83	0.21	0.21	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	33.74	87.51	11.92	9.90	0.22	0.00	0.00	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	33.92	83.14	9.50	9.69	0.19	0.19	0.19	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	40.96	88.24	10.46	11.77	0.00	0.22	0.00	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	30.76	90.59	9.93	9.20	0.97	0.73	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	39.11	87.20	9.62	10.69	0.43	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	41.73	128.68	22.61	23.76	0.00	0.00	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	39.61	122.48	18.59	16.57	0.00	0.40	1.62	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	34.96	122.78	20.33	21.14	0.00	0.00	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	22.57	20.47	4.19	1.61	0.32	0.16	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	24.96	18.34	3.76	1.05	0.00	0.00	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	26.57	19.54	3.07	2.63	0.22	0.22	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	23.64	18.86	6.54	0.75	0.00	0.00	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	21.62	20.97	3.71	1.75	0.22	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	24.89	21.93	3.37	2.95	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	28.79	17.06	6.40	1.07	0.00	0.00	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	23.77	19.86	13.69	1.81	0.00	0.00	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	22.85	19.51	11.90	2.14	0.40	0.00	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	26.93	23.13	11.39	3.11	0.00	0.52	0.17	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	25.98	24.95	9.57	1.55	0.00	0.39	0.13	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	29.36	26.94	8.25	2.43	0.24	0.24	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	31.22	22.19	14.45	3.87	0.26	0.00	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	28.49	28.17	15.19	2.53	0.32	0.00	0.32	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	29.12	26.37	17.58	1.10	0.55	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	44.32	28.53	37.25	5.42	0.00	0.24	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	41.03	26.97	24.23	5.33	0.32	0.65	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	39.99	30.22	31.31	4.16	0.36	0.72	0.18	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	39.98	32.45	38.94	4.19	0.21	0.00	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	35.95	26.57	40.44	2.34	0.20	0.20	0.39	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	41.57	23.00	35.03	4.85	0.21	0.42	0.00	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	60.53	32.99	44.86	3.96	0.33	0.49	0.49	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	49.18	30.85	48.06	5.42	0.56	0.37	0.19	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	46.56	31.43	53.85	5.56	0.57	0.77	0.57	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	51.30	37.61	63.97	4.29	0.20	0.82	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	52.39	31.83	57.63	4.03	0.20	0.40	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	71.31	35.92	65.09	6.75	0.81	1.08	0.81	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	67.46	39.13	74.66	5.04	0.48	0.48	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	59.05	31.52	67.99	4.71	0.00	0.00	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	64.85	28.84	68.81	4.98	0.15	0.59	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	61.37	33.74	69.38	3.59	0.21	0.42	0.63	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	53.32	31.12	68.01	4.72	0.35	0.35	0.17	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	65.25	36.14	85.53	5.02	0.00	0.80	1.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	53.74	30.71	78.40	4.65	0.23	0.00	0.93	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	52.30	34.07	66.69	5.04	0.48	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	55.14	31.59	76.30	4.77	0.30	0.89	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	45.96	23.22	59.36	3.83	0.24	0.24	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	44.48	26.08	53.38	4.04	0.00	0.61	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	47.55	20.29	56.36	4.92	0.20	0.20	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	45.81	28.24	53.15	4.45	0.44	0.89	0.44	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	293.84	55.97	419.77	13.99	0.00	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	36.20	28.03	57.13	5.32	0.00	0.35	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	33.80	28.83	45.73	4.64	0.00	0.33	0.33	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	137.59	52.01	121.65	10.07	0.00	1.68	4.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	71.64	27.55	57.86	2.30	0.46	1.38	0.92	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	38.57	44.40	51.86	7.45	0.00	0.97	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	27.94	38.54	47.21	5.14	0.32	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	69.47	37.09	70.72	1.89	0.63	1.89	0.31	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	26.79	26.79	23.27	3.53	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	30.28	36.45	28.04	5.61	0.00	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	82.00	40.60	50.16	5.57	0.00	2.39	2.39	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	39.41	23.44	24.80	4.08	0.34	0.34	0.34	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	28.59	33.47	24.69	6.82	0.32	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	26.27	30.53	13.84	7.10	0.35	0.00	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	161.64	64.66	113.15	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	221.13	31.59	126.36	23.69	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	24.38	24.86	10.24	3.90	0.00	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	25.29	24.30	5.45	3.97	0.00	0.50	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	29.55	20.17	7.04	2.35	0.00	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	37.42	28.81	10.60	5.96	0.00	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	25.68	28.15	12.68	4.02	0.62	0.31	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	23.54	28.43	11.92	6.42	0.00	0.00	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	33.58	9.98	1.27	1.43	0.16	0.00	0.00	1.11
Adipocyte - breast, donor2	11327-117E4	26.79	8.98	3.69	1.12	0.16	0.32	0.32	0.48
Adipocyte - omental, donor1	11473-119C6	37.79	7.51	4.83	0.89	0.25	0.00	0.13	0.64
Adipocyte - omental, donor2	11474-119C7	18.69	5.98	2.24	1.49	0.75	0.00	0.00	1.49
Adipocyte - omental, donor3	11475-119C8	24.78	5.02	4.69	0.33	0.33	0.00	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	32.54	11.48	4.47	0.64	0.64	0.00	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	7.70	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	27.55	14.45	6.77	0.45	0.00	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	24.50	12.34	9.38	1.74	0.52	0.00	0.00	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	100.33	24.45	142.38	5.28	0.00	0.00	0.20	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	82.10	29.08	78.76	7.98	0.00	0.00	0.00	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	78.89	27.60	89.76	3.35	0.00	0.84	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	127.55	30.57	116.97	7.05	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	56.30	25.66	37.80	2.98	0.16	0.00	0.08	1.45
Adipocyte differentiation, day08, donor2	13023-139D8	88.11	27.11	94.57	2.90	0.32	0.00	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	61.32	26.13	34.12	2.67	0.53	0.53	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	57.31	27.27	25.04	4.45	0.00	0.56	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	28.70	17.88	9.15	0.83	0.83	0.00	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	49.73	19.84	55.01	2.76	0.00	0.75	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	43.85	18.33	28.47	1.31	0.00	0.65	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	45.98	20.70	14.01	2.13	0.61	0.61	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	17.90	13.26	1.99	1.10	0.22	0.22	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	6.45	5.38	1.08	0.00	0.00	0.00	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	17.97	2.40	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	21.95	17.45	1.98	1.08	0.00	0.00	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	5.02	3.35	0.00	0.00	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	16.23	12.12	0.62	0.62	0.21	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	62.48	34.33	9.84	2.63	0.46	0.80	0.00	1.26
Anulus Pulposus Cell, donor2	11463-119B5	37.23	23.02	7.35	2.69	0.24	0.00	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	46.28	17.97	14.38	3.59	0.00	0.90	1.35	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	45.15	13.46	21.71	3.04	0.00	0.00	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	44.95	19.26	12.84	4.28	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	43.64	12.85	18.83	2.69	0.00	0.90	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	27.82	13.91	20.23	2.53	0.00	2.53	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	26.40	15.18	17.82	1.98	0.00	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	38.66	13.97	24.04	1.95	0.32	0.32	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	45.15	18.45	20.39	0.97	1.46	0.49	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	26.13	13.66	14.85	0.59	0.00	1.19	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	42.94	13.94	19.96	2.26	0.38	0.38	0.75	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	56.60	20.32	21.04	5.08	0.00	0.00	0.73	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	20.06	6.27	16.30	2.51	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	37.72	19.27	25.37	2.97	0.00	0.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	50.50	12.28	6.82	0.00	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	26.84	19.90	20.96	2.11	0.15	0.00	0.30	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	47.15	16.07	19.29	1.61	1.07	0.54	2.14	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	33.82	13.60	25.70	1.70	0.00	0.19	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	32.07	18.18	18.71	1.34	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	30.24	10.73	17.56	2.93	0.00	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	33.34	16.25	19.41	1.99	0.00	0.17	0.33	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	18.01	14.41	12.01	2.40	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	10.62	7.08	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	33.79	17.84	32.93	4.46	0.34	0.51	0.17	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	25.17	8.39	4.19	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	34.95	16.50	10.68	1.94	0.49	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.77	14.04	15.56	0.76	0.00	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	35.13	7.27	10.90	2.42	0.00	0.00	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	40.47	13.68	10.83	3.99	0.00	1.71	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	29.07	18.81	10.69	0.86	0.21	0.64	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	23.49	13.68	6.71	0.77	0.00	0.00	0.52	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	49.27	15.95	14.08	2.35	0.00	0.94	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	35.69	18.33	20.90	1.61	0.32	0.00	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	32.11	15.70	12.84	2.14	0.00	0.00	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	35.10	10.53	15.21	1.75	0.00	1.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	30.11	17.16	15.96	1.51	0.00	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	19.01	14.26	15.44	2.38	0.00	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	42.21	13.22	19.83	4.07	0.00	1.02	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	36.42	14.52	31.07	2.80	0.00	1.02	0.51	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.06	13.34	13.34	1.91	0.00	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	36.68	17.26	18.56	0.00	0.00	0.86	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	31.54	17.36	26.04	1.27	0.00	0.42	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	23.20	15.66	14.21	2.03	0.00	0.58	0.29	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	34.96	14.17	20.78	0.00	0.00	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	26.95	14.92	21.87	1.36	0.34	0.17	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	30.11	23.16	20.85	0.00	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	69.71	14.79	40.14	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	46.53	20.15	68.61	3.43	0.00	1.29	0.21	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.68	20.46	23.46	2.41	0.00	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	60.51	12.39	50.30	3.64	0.00	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	40.46	18.85	74.25	2.99	0.00	1.15	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	45.91	15.30	40.80	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	38.13	19.32	69.66	3.56	0.00	0.76	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	40.05	19.61	82.99	4.95	0.00	2.48	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	35.80	18.05	49.57	3.37	0.92	0.61	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	54.49	12.91	52.58	2.87	0.00	3.82	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	42.35	16.63	65.41	3.33	0.00	0.89	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	39.67	15.26	47.30	1.53	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	50.40	12.74	57.05	2.77	0.00	1.11	0.55	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	39.72	18.54	47.66	1.85	0.26	0.53	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	30.53	16.72	37.80	3.27	0.36	1.09	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	18.55	14.86	1.97	0.98	0.37	0.00	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	15.75	10.44	1.20	0.68	0.17	0.17	0.00	0.51
Astrocyte - cerebellum, donor3	11661-122F5	14.26	6.29	1.05	0.84	0.21	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	60.65	30.33	8.02	2.79	0.35	0.35	0.00	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	57.91	41.41	6.63	3.40	0.16	0.00	0.00	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	52.50	33.71	11.49	2.39	0.30	0.45	0.00	1.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	60.67	61.82	4.93	1.83	0.23	0.57	0.23	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	63.27	65.02	5.39	2.76	0.13	0.13	0.25	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	57.01	64.30	4.44	2.62	0.11	0.00	0.00	0.80
Basophils, donor1	12241-129G9	84.48	58.58	17.52	3.40	0.26	0.00	0.26	0.00
Basophils, donor2	12242-129H1	173.18	124.47	32.11	2.53	0.36	0.36	0.00	0.00
Basophils, donor3	12243-129H2	85.11	79.97	23.96	2.65	0.00	0.29	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	10.56	5.61	0.00	0.22	0.00	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	7.77	4.11	0.91	0.46	0.00	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	13.81	21.34	1.26	3.77	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	14.35	17.05	1.25	1.04	0.00	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	25.79	25.10	2.07	2.07	0.00	0.23	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	30.05	19.79	0.90	1.08	0.00	0.18	0.18	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	54.52	97.08	6.39	7.83	0.10	0.10	0.21	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	70.10	79.65	7.22	3.26	0.00	0.47	0.23	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	76.75	81.22	16.95	2.56	0.64	0.00	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	155.13	103.42	31.03	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	133.00	69.88	137.51	4.51	0.00	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	141.06	78.32	104.86	3.53	0.19	0.56	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	117.89	73.33	105.38	5.49	0.00	0.44	0.22	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	87.46	54.63	7.08	5.94	0.00	0.00	0.57	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	73.54	48.90	5.69	4.17	0.38	0.00	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	77.91	62.79	7.56	4.27	0.33	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	98.44	55.80	40.47	5.20	0.14	0.29	0.43	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	76.04	72.12	30.78	8.75	0.00	0.00	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	101.39	65.86	36.24	6.63	0.71	0.71	0.24	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	119.35	61.27	161.71	10.21	0.50	0.84	1.51	1.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	102.68	69.28	171.68	14.90	0.00	0.55	1.38	1.93
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	134.63	70.16	267.27	15.37	0.25	0.99	1.49	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	118.66	55.61	195.60	11.16	0.20	0.78	1.57	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	107.90	69.97	170.04	12.29	0.36	0.89	1.60	2.49
CD14+ monocytes - treated with BCG, donor3	11880-125C8	152.99	74.65	297.07	13.71	1.09	1.96	2.61	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	126.19	62.28	416.28	15.69	0.00	1.64	1.87	1.87
CD14+ monocytes - treated with Candida, donor2	11878-125C6	149.96	110.36	422.95	29.57	0.53	1.06	1.58	4.22
CD14+ monocytes - treated with Candida, donor3	11888-125D7	207.45	77.66	500.32	14.42	0.00	1.11	3.33	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	105.31	56.67	86.42	7.59	0.30	0.30	1.93	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	91.19	62.06	85.41	13.77	0.60	0.00	0.80	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	161.77	77.66	168.02	12.08	0.00	0.62	0.62	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	122.40	51.48	369.95	12.81	0.69	1.37	2.52	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	106.09	70.80	291.35	15.38	0.23	0.68	1.36	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	104.75	51.94	408.96	12.66	0.00	1.75	3.49	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	103.02	65.90	54.87	7.53	0.27	1.08	0.54	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	109.04	73.97	72.40	10.12	0.87	0.35	1.57	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	137.19	78.27	70.28	8.42	0.42	1.68	0.42	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	145.32	56.95	611.76	17.64	0.00	4.41	5.88	1.29
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	120.12	75.38	721.44	26.77	0.70	0.70	3.52	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	160.13	56.60	765.14	16.23	1.32	1.32	1.75	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	102.18	57.02	105.15	9.07	0.52	0.70	2.79	2.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	105.18	80.65	105.93	12.27	0.37	1.12	0.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	174.81	86.00	194.64	13.58	0.00	0.43	1.72	2.37
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	127.76	50.37	539.30	19.25	0.00	2.46	4.09	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	133.98	75.33	647.41	22.25	0.23	1.16	1.62	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	177.47	66.58	773.69	17.86	0.46	2.32	5.10	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	69.75	53.84	4.80	1.96	0.22	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	89.16	53.59	9.93	3.00	0.46	0.69	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	71.48	47.01	8.88	3.25	0.43	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	96.70	56.84	5.92	3.11	0.00	0.16	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	92.56	58.16	6.46	2.10	0.00	0.17	0.52	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	122.63	80.05	6.91	4.01	0.45	0.00	0.67	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	65.32	44.15	5.87	2.55	0.51	0.26	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	97.27	43.91	5.05	2.85	0.00	0.00	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	85.06	49.27	7.58	4.00	0.21	0.00	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	107.71	103.65	2.03	4.06	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	115.26	88.14	4.75	3.39	0.00	0.00	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	125.31	99.42	7.25	3.11	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	109.81	91.15	8.00	8.00	0.53	0.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	175.83	105.61	11.79	5.36	0.00	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	98.97	84.93	6.32	4.91	0.00	0.70	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	98.04	76.08	2.35	5.49	1.57	0.00	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	114.69	87.01	7.91	3.95	0.00	0.00	2.64	1.32
CD19+ B Cells, donor1	11544-120B5	103.56	154.52	10.68	4.11	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	118.24	162.50	10.88	2.90	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	101.47	157.00	12.62	5.55	0.00	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	126.07	74.35	5.66	4.44	0.00	0.00	0.40	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	109.06	60.72	3.60	6.79	0.40	0.40	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	45.18	56.23	9.04	4.02	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	119.67	97.75	89.33	6.74	0.56	1.12	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	60.12	76.28	11.65	2.63	0.00	0.00	0.75	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	71.03	73.73	9.92	3.38	0.45	0.00	0.23	0.90
CD4+ T Cells, donor1	11225-116C1	273.86	147.46	44.99	2.50	0.36	0.36	0.71	0.36
CD4+ T Cells, donor2	11306-117C1	214.94	130.43	26.94	3.67	0.00	0.61	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	114.98	124.13	30.50	5.18	0.00	0.00	0.91	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	128.64	71.47	1.53	2.04	0.26	0.26	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	112.07	69.85	1.12	2.02	0.00	0.45	0.00	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	117.00	73.02	0.86	2.01	0.00	0.29	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	177.78	110.46	9.96	2.37	0.00	0.00	0.00	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	181.90	92.71	11.94	2.81	0.70	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	131.85	105.48	6.59	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	100.73	62.43	3.18	1.88	0.14	0.00	0.00	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	74.06	62.02	1.02	3.22	0.00	0.34	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	69.80	55.29	1.29	1.61	0.16	0.16	0.16	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	133.14	99.07	12.55	1.34	0.00	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	139.41	88.40	6.29	2.80	0.35	0.35	1.05	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	141.67	90.20	8.36	3.96	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	114.26	78.43	2.11	1.26	0.42	0.00	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	85.19	64.62	2.29	2.70	0.00	0.21	0.21	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	77.85	70.17	3.34	2.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	132.98	90.01	12.78	1.36	0.00	0.00	0.27	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	162.39	85.22	12.86	2.14	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	111.18	71.73	10.76	1.79	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	113.48	84.18	2.97	1.85	0.37	0.00	0.37	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	95.31	71.05	3.03	3.47	0.22	0.00	0.22	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	97.72	71.24	4.20	1.26	0.21	0.00	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	132.47	83.93	9.61	1.52	0.51	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	128.68	91.85	12.56	1.30	0.00	0.00	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	158.64	80.19	8.28	2.18	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	176.67	91.55	7.42	4.95	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	148.63	76.62	8.31	1.85	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	154.94	89.33	8.37	4.19	0.00	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	174.74	102.46	8.31	4.43	0.28	0.28	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	169.32	108.95	8.59	6.63	0.74	0.00	0.00	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	115.50	98.56	7.70	7.70	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	170.46	95.26	7.52	3.22	0.72	0.00	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	191.13	98.33	11.08	4.15	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	136.85	102.47	38.31	2.95	0.33	0.65	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	162.56	107.00	32.66	3.38	0.00	1.50	1.50	0.38
CD8+ T Cells, donor3	11383-118B6	185.83	121.45	43.43	1.26	0.25	0.50	0.25	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	30.97	43.81	4.13	2.06	0.46	0.23	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	28.28	43.14	3.12	1.92	0.48	0.00	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	32.28	42.68	1.92	1.92	0.00	0.27	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	34.22	51.94	3.60	5.10	0.00	0.00	0.00	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	31.68	48.00	3.60	2.16	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	31.15	42.98	3.64	2.96	0.23	0.00	0.00	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	28.46	39.55	4.56	3.91	0.00	0.22	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	29.22	39.74	2.63	2.37	0.26	0.53	0.00	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	30.25	45.03	2.11	2.81	0.00	0.23	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	32.90	45.89	2.42	1.51	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	29.92	38.64	2.32	2.61	0.00	0.00	0.00	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	30.37	43.16	4.80	3.73	0.53	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	36.77	38.96	24.08	4.38	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	31.42	35.52	18.22	6.38	0.00	0.46	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	43.26	44.75	14.17	5.97	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	41.06	44.30	4.68	3.60	0.00	0.72	0.00	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	35.39	46.32	4.32	4.03	0.00	0.29	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	31.58	45.25	3.77	4.24	0.24	0.00	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	31.69	42.78	6.97	3.49	0.32	0.00	0.00	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	33.22	42.14	5.84	4.31	0.00	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	32.70	39.43	7.69	2.56	0.00	0.64	0.32	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	32.51	47.04	6.12	3.82	0.38	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	37.44	41.38	7.49	0.39	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	30.26	44.63	3.03	2.27	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	93.14	88.33	40.95	10.44	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	68.54	58.05	36.37	16.09	0.00	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	81.14	86.15	42.07	7.01	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	80.42	14.62	10.97	1.83	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	27.17	22.73	4.45	0.99	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	43.15	19.47	5.37	1.79	0.32	0.11	0.00	0.63
Chondrocyte - de diff, donor1	11261-116G1	37.09	25.65	8.67	2.08	0.69	0.69	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	32.69	23.45	6.04	2.13	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	38.12	17.64	14.68	1.37	0.46	0.91	0.11	0.46
Chondrocyte - re diff, donor2	11339-117F7	76.10	52.82	24.17	4.48	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	37.21	22.24	30.73	2.43	0.00	0.00	0.81	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	56.92	45.21	3.67	2.52	0.00	0.11	0.00	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	37.20	26.29	3.63	1.28	0.21	0.00	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	40.44	29.29	5.13	1.86	0.44	0.00	0.09	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	58.32	36.41	6.24	3.85	0.64	0.37	0.18	1.65
Corneal Epithelial Cells, donor1	11526-119I5	12.08	7.03	0.66	0.44	0.44	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	19.34	3.41	1.14	2.28	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	17.38	7.41	0.51	0.26	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	45.57	33.51	2.97	1.65	0.33	0.00	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	45.73	31.23	3.47	2.21	0.00	0.00	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	65.56	24.15	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	43.20	31.53	4.43	1.30	0.22	0.22	0.00	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	135.97	96.00	21.18	1.02	0.34	0.00	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	135.80	115.56	18.28	3.26	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	110.82	123.89	20.81	4.36	0.00	0.48	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	43.53	23.01	5.84	1.33	0.50	0.00	0.17	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	23.47	15.26	2.93	0.00	0.00	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	29.41	13.57	2.26	0.28	0.28	0.00	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	31.45	18.87	3.54	0.79	0.39	0.00	0.00	1.57
Endothelial Cells - Artery, donor1	11264-116G4	15.13	9.31	2.62	0.29	0.58	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	25.17	17.65	2.59	0.71	0.47	0.00	0.00	1.18
Endothelial Cells - Artery, donor3	11413-118E9	25.24	14.73	3.33	0.70	0.18	0.18	0.00	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	36.35	17.29	3.10	0.89	0.22	0.00	0.22	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	35.29	23.73	5.17	3.04	0.30	0.00	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	51.59	30.16	9.30	3.10	0.28	0.00	0.28	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	18.13	18.13	5.05	0.89	0.59	0.00	0.30	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	35.41	18.22	14.06	1.04	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	18.29	13.90	3.12	1.13	0.00	0.14	0.00	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	42.01	32.41	4.80	1.20	0.00	0.00	0.00	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	19.39	8.91	0.52	0.52	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	61.87	38.64	4.47	0.87	0.62	0.00	0.37	1.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	57.36	30.20	3.48	2.17	0.22	0.22	0.00	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	61.67	32.24	4.64	2.32	0.12	0.12	0.00	0.49
Endothelial Cells - Vein, donor1	11267-116G7	18.20	21.61	1.14	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	27.24	17.46	1.40	0.70	0.70	0.00	0.00	2.10
Endothelial Cells - Vein, donor3	11416-118F3	29.83	19.00	4.24	1.57	0.16	0.16	0.00	0.16
Eosinophils, donor1	12244-129H3	213.46	167.72	30.49	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	589.14	201.33	207.93	11.55	3.30	0.00	1.65	1.65
Eosinophils, donor3	12246-129H5	435.15	121.27	156.94	7.13	0.00	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	10.26	4.64	0.49	0.49	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	10.40	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	32.54	0.00	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	34.48	22.99	5.75	1.64	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	23.76	7.99	21.79	0.77	0.00	0.88	0.33	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	37.59	13.11	3.68	1.30	0.33	0.22	0.11	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	43.66	17.59	6.19	1.58	0.49	0.12	0.00	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	33.57	11.60	33.71	1.91	0.55	0.00	0.14	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	36.60	13.92	31.11	2.00	0.32	0.21	0.63	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	20.55	15.81	2.11	0.53	0.00	0.00	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	45.84	17.61	6.64	2.66	0.66	0.66	0.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	29.49	19.51	5.90	1.36	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	18.95	16.67	6.06	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	21.61	7.73	7.10	1.10	0.16	0.00	0.00	0.32
Fibroblast - Cardiac, donor4	11452-119A3	45.16	22.43	6.67	2.12	0.30	0.00	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	41.75	23.60	16.24	2.16	0.00	0.38	0.38	0.13
Fibroblast - Cardiac, donor6	11460-119B2	35.17	22.13	4.40	1.82	0.15	0.30	0.00	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	23.58	12.60	0.80	1.07	0.00	0.00	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	47.03	22.00	3.88	1.73	0.00	0.43	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	43.94	30.76	1.46	0.00	0.00	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	35.52	17.53	2.54	0.46	0.00	0.00	0.23	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	51.90	27.14	6.11	0.85	0.34	0.17	0.00	0.51
Fibroblast - Dermal, donor1	11269-116G9	33.10	15.97	7.98	1.41	0.23	0.00	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	41.98	24.53	2.83	0.94	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	44.73	16.68	13.78	1.45	0.60	0.60	0.12	0.85
Fibroblast - Dermal, donor4	11450-119A1	48.72	30.18	5.77	2.83	0.45	0.00	0.11	0.34
Fibroblast - Dermal, donor5	11454-119A5	48.85	43.26	5.58	2.62	0.52	0.17	0.17	0.70
Fibroblast - Dermal, donor6	11458-119A9	50.84	37.52	7.15	3.57	0.16	0.49	0.00	0.49
Fibroblast - Gingival, donor1	11237-116D4	46.85	20.61	3.12	1.25	0.42	0.00	0.00	1.46
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	55.02	26.20	3.14	1.83	0.00	0.00	0.00	0.52
Fibroblast - Gingival, donor2	11318-117D4	52.98	30.44	3.29	1.58	0.66	0.40	0.26	0.79
Fibroblast - Gingival, donor3	11394-118C8	53.95	22.72	6.09	1.55	0.10	0.00	0.10	1.06
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	74.80	19.74	43.63	3.12	1.04	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	43.35	15.33	19.03	3.00	0.88	0.18	0.53	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	61.11	39.13	8.11	1.87	0.16	0.16	0.31	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	43.00	28.26	3.25	0.81	0.14	0.14	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	38.82	28.23	1.76	1.41	0.00	0.00	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	51.77	28.37	4.97	0.88	0.58	0.00	0.00	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	45.41	31.36	5.32	2.32	0.27	0.00	0.00	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	53.31	48.26	4.72	3.07	0.11	0.00	0.33	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	55.76	19.22	2.93	1.32	0.00	0.15	0.00	0.44
Fibroblast - Lung, donor1	11270-116H1	23.11	8.16	0.00	0.00	0.00	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	43.27	28.35	2.98	0.00	1.49	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	33.34	18.99	2.53	0.84	0.42	0.42	0.00	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	13.33	6.66	0.83	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	22.38	2.80	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	11.47	1.68	1.12	0.00	0.00	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	33.70	16.24	2.03	0.00	0.00	0.00	0.00	1.22
Fibroblast - Mammary, donor2	11620-122A9	15.98	7.99	7.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	60.13	28.90	3.69	2.91	0.58	0.19	0.39	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	73.87	35.65	6.07	2.58	0.76	0.00	0.15	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	52.63	33.35	5.81	2.75	0.00	0.00	0.00	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	41.22	20.99	4.96	0.38	0.76	0.38	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	41.58	15.39	2.97	2.16	0.54	0.27	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	46.74	19.14	30.39	2.90	0.46	0.23	0.00	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	41.34	18.57	5.42	1.11	0.11	0.33	0.00	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	25.40	10.77	1.83	1.22	0.00	0.00	0.00	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	26.73	8.69	4.68	0.00	0.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	28.07	17.79	9.09	0.40	0.79	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	27.58	22.82	2.98	1.19	0.00	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	44.23	13.14	4.80	0.53	0.00	0.00	0.00	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	51.44	19.31	5.52	0.79	0.39	0.00	0.00	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.38	14.14	1.50	0.00	0.00	0.00	0.00	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	49.55	17.49	9.18	0.76	0.11	0.22	0.22	1.19
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	29.86	16.20	1.77	0.25	0.00	0.00	0.00	0.76
Fibroblast - skin normal, donor1	11553-120C5	37.74	22.64	2.63	0.82	0.49	0.00	0.66	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	35.09	26.67	2.01	1.40	0.20	0.00	0.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	48.12	23.11	4.02	1.41	0.10	0.10	0.10	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	35.97	18.13	1.51	1.21	0.30	0.00	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	55.01	18.56	5.30	1.33	0.17	0.00	0.08	1.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	57.61	15.39	5.30	1.03	0.51	0.17	0.00	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	23.98	12.15	0.33	0.33	0.66	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	43.35	20.56	4.79	0.75	0.43	0.00	0.00	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	41.83	24.29	3.88	0.67	0.34	0.34	0.00	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	52.06	16.00	3.92	1.41	0.31	0.00	0.16	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	443.20	132.96	0.00	0.00	0.00	0.00	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	77.57	38.35	6.10	1.74	0.87	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	38.31	30.86	3.47	2.43	0.00	0.35	0.00	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	36.43	32.01	9.63	3.12	0.00	0.00	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	41.14	32.96	6.90	2.30	0.26	0.00	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	57.42	68.13	8.42	5.36	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	63.17	72.10	8.93	7.66	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	88.15	76.45	21.11	5.99	0.00	0.29	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	76.38	63.42	14.34	3.31	0.00	0.55	0.00	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	47.95	50.23	10.96	4.57	0.23	0.00	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	55.28	58.25	13.08	3.96	0.00	0.40	0.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	57.63	60.80	10.84	3.44	0.00	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	58.71	60.34	12.72	6.20	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	62.35	63.68	10.17	4.86	0.00	0.44	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	52.43	32.50	7.07	2.97	0.28	0.28	0.42	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	50.00	31.40	7.02	2.96	0.12	0.12	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	46.47	36.00	8.06	6.98	0.00	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	51.42	25.65	5.08	1.98	0.25	0.00	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	51.36	29.21	5.81	3.32	0.28	0.28	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	42.49	34.56	5.49	3.46	0.20	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	35.14	28.98	3.42	2.51	0.23	0.23	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	48.46	23.42	3.86	2.12	0.12	0.25	0.25	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	43.72	26.01	2.40	2.19	0.00	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	39.00	30.43	4.43	2.07	0.30	0.00	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	49.91	26.55	3.18	2.54	0.48	0.79	0.32	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	41.33	24.35	4.69	2.68	0.00	0.22	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	45.77	36.50	5.04	2.02	0.20	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	54.79	27.48	2.04	2.37	0.17	0.34	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	53.91	39.46	4.43	3.72	0.27	0.09	0.00	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	41.62	27.47	3.33	3.02	0.31	0.00	0.10	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	39.96	32.62	3.24	2.22	0.51	0.00	0.00	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	46.70	28.44	3.43	2.10	0.11	0.00	0.00	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	49.25	36.11	4.83	2.83	0.42	0.17	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.74	40.43	4.29	2.04	0.00	0.00	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	38.37	25.38	1.86	1.03	0.21	0.21	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	53.15	23.06	3.00	2.42	0.00	0.23	0.00	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	35.02	29.85	3.84	2.00	0.33	0.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	34.83	18.96	3.31	1.10	0.00	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	49.32	19.43	5.04	1.72	0.12	0.00	0.00	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	35.82	22.21	4.70	2.43	0.32	0.00	0.00	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	41.05	22.77	2.25	0.96	0.32	0.00	0.00	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	39.04	20.85	2.84	0.95	0.19	0.09	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	36.22	19.46	3.48	1.74	0.16	0.16	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	30.41	26.76	3.95	0.91	0.61	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	41.40	19.76	3.66	1.15	0.10	0.10	0.00	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	33.37	18.88	2.20	1.76	0.22	0.22	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	37.31	24.97	3.09	1.40	0.00	0.00	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	37.96	19.54	2.59	1.48	0.09	0.09	0.37	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	28.34	22.46	1.60	2.14	0.00	0.00	0.00	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	37.03	23.26	1.38	1.38	0.00	0.15	0.15	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	36.92	18.14	3.11	1.55	0.65	0.00	0.00	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.57	19.52	1.63	1.36	0.00	0.00	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	38.71	23.78	2.77	2.77	0.00	0.00	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	35.75	19.74	1.54	1.75	0.44	0.00	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	27.77	21.82	0.00	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	39.57	22.43	2.51	1.98	0.00	0.13	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	37.53	15.33	4.04	0.81	0.00	0.40	0.20	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	45.24	20.84	2.80	0.51	0.25	0.00	0.00	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	53.35	49.17	8.36	7.96	0.00	0.40	0.20	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	48.53	29.43	8.78	4.31	0.00	0.15	0.15	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	77.33	46.03	5.52	5.93	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	46.00	63.52	12.83	3.13	0.00	0.31	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	52.56	50.29	9.61	7.35	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	74.72	50.27	10.61	4.15	0.00	0.00	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	54.45	19.80	9.90	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	73.88	70.79	11.22	8.12	0.00	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	62.57	99.48	12.84	8.02	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	60.86	78.25	6.96	8.69	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	68.35	66.07	7.81	5.86	0.00	0.33	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	70.83	58.06	9.06	6.59	0.00	0.82	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	66.65	10.00	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	74.11	63.76	6.43	7.83	0.00	0.56	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	68.31	62.10	3.60	5.56	0.00	0.00	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	67.95	52.01	5.03	4.19	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	75.70	66.16	6.68	4.77	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	58.76	60.12	6.45	5.43	0.34	0.68	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	89.79	45.94	6.26	2.09	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	91.63	63.00	8.59	6.87	0.00	0.57	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	49.43	37.29	2.96	3.26	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	67.77	67.77	10.16	1.69	0.00	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	84.08	62.13	7.87	6.21	0.41	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	66.28	67.20	8.05	7.59	0.23	0.46	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	115.91	31.61	5.27	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	65.73	51.90	6.15	5.38	0.00	0.00	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	63.56	46.94	5.87	5.87	0.33	0.00	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	70.90	50.83	4.01	6.02	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	68.96	39.30	5.39	3.85	0.77	0.77	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	88.67	110.58	15.41	14.38	0.34	0.68	0.34	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	49.70	62.12	4.97	2.48	0.00	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	72.19	48.60	5.19	4.72	0.00	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	72.42	50.09	4.22	2.41	0.00	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	57.99	42.22	10.17	1.02	0.00	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	58.63	48.26	7.58	2.39	0.40	0.40	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	78.94	42.92	5.43	1.48	0.00	0.49	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	64.92	37.77	9.44	3.54	0.00	2.36	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	58.93	50.18	4.67	2.92	0.00	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	66.71	28.97	3.51	2.63	0.00	0.88	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	71.21	44.93	10.17	1.70	0.00	1.70	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	53.13	46.56	4.18	4.18	0.00	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	49.01	43.67	4.37	1.94	0.00	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	33.10	28.53	59.35	5.71	0.00	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	25.78	13.72	7.90	0.83	0.00	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	20.24	20.24	2.25	0.00	1.12	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	36.16	10.47	13.32	0.63	0.00	0.32	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	24.65	10.86	6.68	2.09	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	20.77	25.41	5.69	1.74	0.00	0.35	0.23	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	20.76	27.51	6.08	3.71	0.00	0.00	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	17.52	26.39	4.10	2.50	0.00	0.23	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	20.77	24.92	6.67	1.64	0.00	0.33	0.22	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	19.34	28.80	6.23	2.36	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	21.96	26.48	4.95	2.15	0.00	0.22	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.81	22.54	8.84	2.99	0.00	0.12	0.12	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	14.92	25.39	6.69	4.12	0.00	0.17	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	19.22	22.75	7.37	2.24	0.32	0.32	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	15.11	8.95	0.56	0.00	0.00	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	11.69	2.60	2.16	0.43	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	21.15	5.29	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	17.28	10.58	1.41	1.06	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	12.35	6.54	0.73	0.00	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	37.42	20.98	4.02	0.87	0.17	0.52	0.00	0.35
Hepatocyte, donor1	11523-119I2	39.95	47.21	2.42	6.05	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	43.09	51.71	2.15	5.39	0.00	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	33.74	37.43	4.29	1.23	0.00	1.84	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	77.02	85.50	11.75	9.14	0.00	0.65	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	47.72	45.79	13.46	5.07	0.17	0.00	0.52	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	28.40	23.33	2.74	0.82	0.27	0.27	0.14	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	25.47	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	20.03	0.00	0.00	0.00	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	54.17	0.00	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	29.07	16.61	2.77	1.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	12.51	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	71.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	15.38	0.00	5.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	32.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	25.99	24.36	3.25	4.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	23.34	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	47.20	0.00	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	23.82	29.12	2.65	1.32	0.00	0.00	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	18.85	21.06	1.11	3.33	0.00	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	31.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	25.82	22.05	0.63	0.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	26.29	0.00	0.00	0.00	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	73.17	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	32.95	26.49	1.94	1.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	19.32	4.83	4.83	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	35.84	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	24.45	25.26	3.26	3.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	19.31	20.15	0.42	0.00	0.00	0.00	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	71.86	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	33.75	19.29	0.80	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	22.16	20.31	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	30.16	0.00	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	25.96	20.77	0.47	3.30	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	13.60	25.40	1.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	29.48	0.00	29.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	19.37	23.67	1.08	4.30	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	22.87	1.27	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	82.15	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	21.04	23.59	1.91	1.91	0.00	0.00	0.00	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	20.05	25.52	3.65	1.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	17.14	26.42	2.86	2.14	0.00	0.71	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	16.59	6.64	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	29.01	20.99	1.54	1.54	0.31	0.00	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	17.56	1.76	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	12.57	0.00	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.73	25.73	1.39	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	26.56	4.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	16.21	0.00	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	30.52	23.54	0.00	3.49	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	40.50	0.00	0.00	0.00	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	41.81	0.00	6.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	17.07	24.54	0.00	2.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	18.01	23.55	0.00	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	19.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	22.09	15.65	0.92	1.84	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	27.23	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	55.88	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	23.26	0.00	2.11	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	19.18	16.56	1.06	0.90	0.08	0.00	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	18.15	22.25	1.17	1.76	0.00	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	48.84	32.18	2.46	2.08	0.19	0.38	0.28	0.09
Keratinocyte - oral, donor1	11251-116E9	68.45	37.12	2.04	2.04	0.34	0.11	0.00	0.23
Keratocytes, donor1	11527-119I6	32.66	8.94	2.41	0.34	0.00	0.00	0.00	0.69
Keratocytes, donor2	11607-120I5	14.06	11.72	1.17	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	63.03	15.21	7.90	1.19	0.00	0.00	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	204.41	103.30	24.18	17.58	0.00	2.20	0.00	4.40
Lens Epithelial Cells, donor1	11529-119I8	21.57	25.89	1.08	1.08	1.08	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	51.44	31.95	5.42	2.54	0.12	0.00	0.00	0.92
Lens Epithelial Cells, donor3	11690-122I7	43.59	19.68	2.52	1.31	0.20	0.00	0.10	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	46.13	27.63	92.61	3.79	0.12	0.24	0.24	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	32.65	20.09	56.65	2.79	0.84	1.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	45.33	28.49	65.48	3.94	0.00	2.05	0.79	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	37.64	18.28	52.16	1.61	0.00	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	22.38	17.33	51.06	2.84	0.32	0.63	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	27.17	17.36	34.50	2.91	0.00	0.65	0.22	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	35.29	24.21	57.04	2.46	0.00	1.64	1.23	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	17.44	13.15	38.43	1.26	0.25	0.00	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	24.77	19.85	38.28	2.82	0.14	0.28	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	38.76	23.73	60.52	2.37	0.00	0.00	1.19	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	34.71	24.04	86.67	4.27	0.19	1.36	0.78	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	17.40	13.89	26.66	1.48	0.00	1.11	0.56	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	36.58	19.16	65.16	3.83	0.00	1.39	1.05	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	32.68	18.84	67.03	1.67	0.24	0.72	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	27.88	20.74	39.83	1.92	0.14	0.27	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	43.42	22.48	74.53	5.54	0.00	1.85	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	23.07	11.85	48.63	2.18	0.62	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	25.62	20.68	26.53	1.83	0.18	0.18	0.37	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	36.20	26.66	60.89	4.28	0.00	1.65	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	21.67	14.35	48.32	0.59	0.29	2.05	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	19.67	13.19	23.65	1.00	0.00	0.25	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	33.46	22.79	69.83	0.48	0.00	0.48	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	28.81	26.93	76.21	3.77	0.00	0.00	0.81	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	32.55	23.16	41.48	2.57	0.00	0.30	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	33.18	20.22	55.99	6.22	0.00	2.07	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	32.87	29.11	92.76	3.98	0.00	1.88	0.84	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	25.71	20.45	40.75	1.65	0.30	0.15	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	39.21	19.26	55.03	2.06	0.00	1.38	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	31.23	22.39	72.25	1.88	0.00	0.75	0.19	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	23.54	14.21	29.69	1.59	0.00	0.64	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	43.13	21.32	61.06	2.91	0.00	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	33.08	21.50	66.16	2.65	0.00	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	23.54	17.84	32.96	1.24	0.00	0.99	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	51.09	24.43	73.67	2.22	0.37	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	35.09	22.73	71.90	3.71	0.25	1.98	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	21.86	17.60	39.05	1.92	0.14	0.55	0.82	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	38.92	24.44	60.47	6.43	0.00	0.96	0.00	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	42.91	32.26	83.99	3.04	0.00	1.22	0.00	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	37.93	25.61	54.87	2.80	0.42	0.84	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	37.69	26.67	53.33	3.91	0.00	1.07	0.00	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	23.27	17.45	38.78	1.45	0.00	0.48	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	15.25	12.92	27.39	2.49	0.00	0.00	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	45.84	21.13	60.16	1.43	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	39.20	18.95	54.55	2.29	0.00	0.65	0.00	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	13.89	10.59	17.42	1.41	0.24	0.47	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	45.54	29.95	83.66	3.09	0.25	0.62	0.25	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	21.00	13.32	38.93	2.05	0.00	0.26	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	27.75	20.29	47.74	2.69	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	38.52	22.66	4.53	4.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	26.85	24.55	6.14	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	22.27	27.46	3.71	1.48	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	22.85	19.04	2.96	1.27	0.85	0.42	0.42	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	20.40	18.29	5.63	0.70	0.00	0.70	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	21.48	19.61	3.74	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	22.67	14.43	1.55	1.55	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	28.55	22.60	2.38	0.00	1.19	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	20.58	20.58	4.07	0.68	0.23	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	20.36	22.10	2.04	1.16	0.29	0.29	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	22.06	19.81	1.35	1.35	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	30.48	24.25	2.17	1.22	0.41	0.00	0.27	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	22.08	24.65	2.57	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	22.23	18.35	2.12	1.41	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	19.99	20.66	3.33	1.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	23.43	27.51	4.08	2.55	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	24.28	18.94	4.27	1.33	0.27	0.53	0.53	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	26.83	21.92	6.05	1.70	0.00	0.38	0.19	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	19.63	26.38	2.45	0.61	0.00	0.00	0.00	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	35.06	25.28	4.89	2.45	0.00	0.00	0.82	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	27.70	20.62	3.75	0.62	0.21	1.04	0.21	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	24.66	25.78	3.64	0.28	0.28	0.56	0.28	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	39.15	20.61	4.12	3.09	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	29.61	20.90	3.19	0.58	0.58	0.58	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	20.93	19.13	3.59	3.59	0.60	0.00	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	30.43	20.47	5.53	1.11	0.55	0.00	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	30.40	25.80	4.95	1.06	0.00	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	21.02	19.18	2.95	2.21	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	18.42	23.03	0.00	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	31.47	26.86	3.45	1.92	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	26.04	23.78	4.53	2.83	0.00	1.13	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.87	14.77	4.10	0.00	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	28.02	24.40	2.26	1.36	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	24.42	12.93	5.75	2.15	0.00	0.00	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.93	23.90	2.99	5.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	26.38	21.55	4.09	2.60	0.00	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	26.71	17.23	5.60	1.29	0.00	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	20.55	11.99	4.28	3.43	0.86	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	28.65	18.99	2.67	2.00	0.00	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	22.93	16.89	1.81	0.60	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	26.31	14.22	2.13	1.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	22.00	15.47	4.47	1.03	0.34	0.34	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	18.25	13.96	2.68	1.61	0.00	0.54	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	22.89	22.22	6.06	0.67	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	28.89	17.04	2.22	0.74	0.37	1.11	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	45.35	19.77	0.00	2.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	22.21	12.69	2.12	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	30.41	18.41	4.80	1.20	0.00	0.40	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	27.62	26.89	3.63	2.18	0.73	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	27.59	26.83	6.90	1.53	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	22.69	28.12	1.97	3.45	0.00	0.49	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	18.82	31.05	2.82	2.82	0.00	0.00	0.00	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	35.20	26.15	5.03	2.01	0.00	0.50	0.00	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	31.99	28.39	6.31	0.90	0.00	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	34.42	34.42	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	29.84	35.18	4.45	0.45	0.45	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	27.76	29.72	4.69	3.13	1.56	1.17	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.81	19.13	0.66	1.32	0.00	0.00	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	30.10	23.87	3.63	2.08	1.04	0.00	0.52	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	33.69	29.32	3.94	1.31	0.44	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	26.28	22.36	2.24	2.24	1.12	0.00	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	25.62	23.41	2.65	0.88	0.00	0.00	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	27.77	28.16	3.47	0.00	0.77	0.39	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	17.22	22.28	3.04	1.01	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	32.20	22.59	3.36	1.44	1.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	31.01	22.26	2.39	1.99	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	26.74	34.63	1.82	2.43	0.00	1.22	0.00	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	26.98	20.75	2.08	1.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	27.74	20.14	2.28	1.90	0.38	0.00	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	29.44	28.92	4.13	0.52	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	22.98	18.14	1.81	0.60	0.00	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	28.84	23.13	3.80	1.90	0.32	0.63	0.32	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	28.79	23.99	8.00	1.60	0.00	0.00	0.00	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	23.56	17.24	4.02	0.57	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	29.31	21.60	5.66	2.06	0.00	0.00	0.51	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.00	29.00	2.83	1.41	1.41	0.00	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	25.54	18.16	4.54	0.57	0.00	0.57	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	30.37	17.89	5.82	1.25	0.83	0.83	0.00	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	26.62	23.49	3.92	1.57	0.00	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	22.55	18.79	3.34	0.84	0.00	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	25.56	16.26	3.72	1.86	0.00	0.00	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	28.77	21.41	1.34	2.68	0.00	0.00	0.00	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	29.41	19.25	3.21	0.53	0.53	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	36.77	19.40	3.64	1.21	0.81	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	31.20	23.86	3.67	2.75	0.92	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	32.01	24.90	3.56	2.67	0.89	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	28.49	25.07	6.27	2.28	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	24.54	17.64	4.60	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	27.91	16.96	3.83	1.09	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	29.40	21.83	3.56	1.34	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	37.17	20.80	5.46	2.34	0.00	0.00	0.00	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	27.19	19.89	4.64	1.33	0.66	0.66	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	22.86	4.16	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	62.22	30.54	7.52	1.60	0.00	0.23	0.00	0.68
Macrophage - monocyte derived, donor2	11313-117C8	31.56	21.65	7.89	0.92	0.37	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	41.55	30.28	11.80	3.15	0.13	0.39	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	16.99	20.71	7.97	5.31	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	38.82	27.73	2.06	3.33	0.00	0.16	0.00	0.16
Mallassez-derived cells, donor3	11930-125I4	48.51	36.41	9.31	3.89	0.00	0.14	0.28	0.56
Mammary Epithelial Cell, donor1	11273-116H4	60.08	64.87	6.38	3.99	0.20	0.10	0.20	0.30
Mammary Epithelial Cell, donor2	11350-117G9	41.12	61.09	6.08	1.74	0.00	0.00	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	20.20	21.95	1.50	1.00	0.00	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	184.40	68.47	61.01	3.39	0.68	0.00	0.00	2.03
Mast cell, donor1	11563-120D6	74.29	54.50	6.06	2.81	0.43	0.00	0.00	0.97
Mast cell, donor2	11565-120D8	112.93	49.63	15.16	0.89	0.00	0.00	0.30	0.59
Mast cell, donor3	11566-120D9	140.25	55.61	10.58	1.80	0.68	0.23	0.68	2.03
Mast cell, donor4	11567-120E1	106.55	48.22	13.30	2.48	0.89	0.18	0.00	2.30
Mast cell, expanded and stimulated, donor5	11940-126A5	77.29	48.35	2.00	2.11	0.22	0.00	0.33	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	54.28	47.28	1.17	2.33	0.58	0.00	0.00	2.33
Mast cell, expanded, donor5	11939-126A4	65.97	42.79	0.92	2.06	0.00	0.00	0.11	1.03
Mast cell, expanded, donor8	11941-126A6	73.98	46.70	2.34	1.34	0.17	0.00	0.00	0.33
Melanocyte - dark, donor1	11502-119F8	43.88	30.65	4.18	2.89	0.20	0.00	0.00	0.40
Melanocyte - dark, donor2	11582-120F7	37.03	26.30	3.46	0.69	0.35	0.00	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	44.41	23.18	9.56	3.11	0.65	0.00	0.07	0.87
Melanocyte - light, donor1	11274-116H5	17.63	7.05	2.35	0.71	0.00	0.00	0.00	0.71
Melanocyte - light, donor2	11351-117H1	15.01	8.19	0.68	0.00	2.05	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	9.54	5.20	4.34	1.73	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	36.76	11.87	3.64	1.04	0.42	0.00	0.10	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	32.27	20.98	4.03	1.88	0.00	0.00	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	49.82	25.45	3.48	1.87	1.07	0.00	0.27	1.87
Meningeal Cells, donor1	11493-119E8	29.03	19.85	1.98	1.74	0.12	0.12	0.00	0.62
Meningeal Cells, donor2	11573-120E7	21.13	24.21	1.76	2.20	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	59.66	39.04	3.50	2.28	0.33	0.00	0.08	0.57
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	56.46	25.09	6.84	2.00	0.29	0.57	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	30.89	17.71	14.89	1.21	0.10	0.10	0.00	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	10.51	3.94	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	7.85	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.86	15.07	2.15	0.72	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	35.58	17.36	5.29	0.85	0.21	0.00	0.00	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	31.16	13.07	3.02	2.51	0.50	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	20.66	9.01	0.66	0.44	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	23.38	10.23	2.92	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	16.57	4.50	1.23	0.41	0.00	0.00	0.00	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	37.81	11.50	4.85	0.42	0.42	0.28	0.14	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	13.01	4.09	2.23	0.37	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	39.60	16.84	4.21	1.32	0.13	0.53	0.26	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	18.69	6.83	2.37	0.59	0.00	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	4.67	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.09	9.61	0.64	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	50.69	21.98	3.90	1.06	0.00	0.71	0.00	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	45.03	14.07	4.07	2.19	0.94	0.00	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	39.19	30.48	3.63	0.73	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	37.39	12.99	28.37	0.27	0.00	0.27	0.27	0.53
Mesothelial Cells, donor2	12156-128G5	39.54	19.02	12.51	2.50	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	26.23	17.56	7.73	1.52	0.22	0.07	0.00	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	41.86	58.06	5.40	5.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	47.53	39.65	6.65	2.96	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	37.69	28.56	3.24	1.47	0.29	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	38.03	3.46	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	35.95	30.06	6.20	2.79	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	28.00	21.99	4.15	0.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	41.69	16.21	9.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	47.05	31.03	32.03	3.00	0.00	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	37.24	32.58	10.24	3.72	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	175.20	19.47	58.40	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	40.85	31.70	38.61	1.63	0.00	0.00	1.02	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	29.30	24.15	28.91	2.38	0.00	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	17.10	59.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	45.13	17.70	69.03	4.42	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	32.29	23.94	37.99	3.42	0.00	0.76	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	52.64	50.00	82.90	3.95	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	47.75	28.44	147.50	8.49	0.00	0.85	0.85	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	43.28	39.60	43.28	2.76	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	63.19	32.49	207.45	9.84	0.30	1.79	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	45.27	26.83	77.13	6.71	0.00	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	67.90	169.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	58.96	39.64	237.61	12.04	0.00	1.76	0.75	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	54.19	28.52	64.65	5.47	0.24	0.95	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	65.79	39.25	222.81	12.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	84.04	40.06	289.88	10.82	0.00	2.07	1.61	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	53.43	29.24	86.45	4.84	0.00	0.63	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	71.75	38.12	286.58	9.17	0.00	0.41	0.61	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	69.08	37.33	202.74	7.72	0.43	1.72	1.07	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	70.69	38.01	118.26	6.67	0.00	0.67	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	41.27	103.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	93.30	41.83	287.57	10.29	0.00	0.88	1.10	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	71.48	38.53	128.77	11.15	0.00	0.51	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	94.45	46.40	147.47	8.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	124.75	57.62	384.04	17.12	0.00	1.90	1.63	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	71.76	34.11	105.87	7.65	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	70.87	49.06	111.21	9.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	95.15	35.56	243.64	13.46	0.00	4.32	1.92	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	60.83	34.42	98.46	4.80	0.00	2.80	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	79.53	34.28	224.88	13.71	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	105.12	42.05	261.30	7.01	0.50	2.00	2.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	53.89	80.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	89.69	26.50	246.66	10.19	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	83.21	45.98	231.66	8.32	0.00	1.75	1.75	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	96.02	45.25	110.37	6.62	0.00	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	74.29	46.75	250.39	10.89	0.00	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	108.59	42.64	262.79	12.15	0.00	0.74	2.23	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	80.72	51.50	151.71	13.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	110.49	30.94	218.78	6.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	81.71	35.56	211.28	6.15	0.00	1.37	0.68	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	85.77	50.33	111.15	10.07	0.00	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	89.84	35.86	185.72	6.75	0.00	0.00	0.36	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	94.83	36.75	203.40	5.61	0.00	1.68	1.68	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	71.90	42.81	103.49	7.07	0.42	0.42	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	76.92	30.30	207.46	12.24	0.00	0.00	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	85.37	31.98	184.92	5.43	0.00	1.81	1.51	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	73.04	32.56	96.42	13.77	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	79.41	43.31	252.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	86.81	38.79	209.65	13.85	0.00	2.77	2.77	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	87.64	43.82	100.16	10.24	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	83.46	30.95	168.58	8.43	0.14	0.83	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	80.85	31.36	169.22	7.52	0.00	0.52	1.04	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	93.09	39.89	117.11	9.87	0.43	0.00	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	73.68	31.12	196.27	8.89	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	102.49	38.97	175.35	7.74	0.00	0.27	1.60	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	94.59	35.62	115.84	6.88	0.00	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	71.05	20.48	169.22	6.22	0.14	0.42	0.42	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	72.94	27.39	127.09	4.78	0.32	1.27	1.91	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	98.40	42.68	110.79	12.16	0.22	0.00	0.44	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	76.22	37.92	195.67	8.34	0.00	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	96.60	31.82	196.60	10.80	0.00	1.42	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	83.82	34.90	107.17	9.59	0.00	0.49	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	69.08	28.67	239.81	10.43	0.00	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	107.03	31.75	210.52	7.94	0.00	2.65	0.29	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	86.50	40.08	127.73	8.36	0.00	0.86	0.86	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	74.19	32.56	187.94	4.53	0.82	0.41	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	90.53	26.20	226.32	7.74	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	52.74	18.83	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	33.86	21.39	7.13	3.56	0.00	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	45.34	37.13	14.13	3.29	0.00	0.33	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	29.45	24.19	12.62	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	36.18	27.28	2.77	2.97	0.00	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	39.12	49.36	7.45	3.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	39.81	50.70	3.38	3.76	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	28.23	27.97	2.66	3.20	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	52.03	33.82	16.06	3.28	0.00	0.23	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	28.00	31.68	8.10	1.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	34.44	36.28	10.99	4.40	0.00	0.37	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	42.00	23.33	7.78	1.56	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	66.80	47.03	57.72	5.88	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	38.64	19.32	23.18	11.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	48.48	38.38	14.14	3.03	0.00	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	45.54	30.36	30.78	6.32	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	35.41	38.13	183.86	8.17	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	50.86	21.62	109.99	6.36	0.00	0.64	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	37.25	25.10	69.65	5.67	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	18.13	10.57	60.42	6.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	199.86	205.57	576.73	57.10	0.00	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	101.14	68.51	274.05	9.79	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	57.03	133.07	4.75	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	100.39	112.94	250.98	100.39	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	32.53	14.65	5.17	1.29	0.22	0.00	0.00	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	41.81	17.25	2.61	1.05	2.09	0.00	0.00	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	13.35	16.02	3.34	0.00	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	21.29	21.70	2.92	2.09	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	75.11	20.35	4.75	0.38	0.00	0.00	0.00	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	116.50	65.43	9.58	3.19	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	11.56	14.28	4.08	0.68	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	130.47	36.75	11.03	3.68	0.00	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.83	14.23	19.25	0.00	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	34.17	24.17	13.02	1.63	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	22.16	17.29	11.62	1.08	0.00	0.00	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	64.75	27.96	47.72	1.05	0.21	0.21	0.00	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	189.29	66.81	211.56	11.13	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	28.79	17.37	53.61	1.49	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	56.57	18.41	57.38	1.35	0.00	0.54	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	23.12	17.00	26.07	2.27	0.23	0.23	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	32.01	16.00	21.88	0.98	0.33	0.00	0.16	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	63.06	20.41	74.54	2.73	0.00	1.46	0.55	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	24.93	18.57	45.62	3.71	0.00	1.06	1.06	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	20.41	16.81	82.84	3.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	105.02	18.05	85.65	1.64	0.98	0.00	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	25.69	13.82	53.02	1.79	0.00	0.16	0.65	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	80.08	29.98	74.26	3.00	0.00	1.41	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	25.32	14.77	53.45	1.41	0.00	0.70	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	45.05	22.53	97.00	0.92	0.00	0.00	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	27.64	15.10	39.53	1.93	0.00	0.00	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	98.64	16.21	144.85	2.07	1.03	1.38	1.38	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	336.28	55.63	171.93	5.06	2.53	2.53	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	79.76	31.41	93.79	5.35	0.22	0.45	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	35.14	15.67	50.38	1.69	0.00	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	62.90	16.61	98.50	1.66	0.00	0.00	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	26.61	18.89	47.65	2.58	0.00	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	433.33	36.11	460.42	9.03	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	27.99	13.33	16.33	2.67	0.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	58.61	26.15	60.42	3.61	0.00	0.00	0.45	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	18.65	13.49	21.03	2.78	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	28.79	10.22	147.65	4.64	0.00	1.86	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	51.08	13.62	36.70	2.27	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	26.40	12.71	44.97	4.56	0.00	0.33	0.65	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.43	11.77	15.25	4.36	0.44	0.00	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	64.22	28.95	36.64	4.07	0.45	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	24.69	15.87	29.10	2.65	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	37.23	16.62	91.75	0.66	0.00	1.33	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	25.30	15.38	28.27	2.98	0.50	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	20.67	16.84	19.52	1.53	0.00	0.00	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	43.55	14.82	14.52	1.81	0.30	0.00	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	55.26	21.66	49.95	2.65	0.00	0.44	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	15.59	14.23	29.82	3.39	0.00	0.00	0.00	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	189.05	61.31	357.67	5.11	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	23.78	14.63	19.51	1.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	24.55	9.13	17.63	1.57	0.31	0.00	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	27.24	16.65	8.78	1.21	0.00	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	17.41	11.08	18.20	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	125.83	13.60	103.16	2.27	0.00	1.13	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	187.14	35.41	166.91	5.06	0.00	0.00	10.12	0.00
Myoblast, donor1	11241-116D8	40.25	16.27	14.04	1.37	0.12	0.12	0.12	0.25
Myoblast, donor2	11322-117D8	47.37	19.18	22.25	0.38	0.00	0.38	0.19	0.00
Myoblast, donor3	11398-118D3	39.18	24.38	17.66	2.69	0.50	0.34	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	43.63	49.03	8.03	6.86	0.00	0.15	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	115.93	115.32	31.37	3.38	0.31	0.00	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	158.62	103.43	24.12	1.51	0.00	1.21	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	119.64	100.49	27.06	1.10	0.37	0.37	0.37	0.00
Neural stem cells, donor1	11275-116H6	76.22	46.46	5.44	3.63	0.73	0.00	0.00	1.45
Neural stem cells, donor2	11352-117H2	113.61	59.69	21.18	1.93	3.85	0.00	0.00	1.93
Neurons, donor1	11494-119E9	100.14	77.38	17.07	7.97	0.00	0.00	0.00	4.55
Neurons, donor2	11574-120E8	72.21	55.04	9.03	3.74	1.54	0.00	0.00	3.96
Neurons, donor3	11655-122E8	79.75	77.28	13.98	6.58	1.64	0.82	0.00	6.58
Neutrophils, donor1	11233-116C9	141.06	84.45	37.12	6.50	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	113.06	40.58	17.39	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	248.00	77.58	65.97	9.77	0.00	0.00	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	68.15	36.33	16.50	1.66	0.36	0.12	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	29.96	19.21	3.26	0.98	0.33	0.00	0.00	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	40.51	28.08	8.02	2.21	0.00	0.40	0.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	42.12	18.58	8.26	1.38	0.41	0.28	0.41	0.41
Olfactory epithelial cells, donor2	11934-125I8	44.58	28.08	7.96	1.88	0.58	1.30	0.43	0.00
Olfactory epithelial cells, donor3	11935-125I9	39.73	25.31	4.54	1.25	0.23	0.57	0.11	1.25
Olfactory epithelial cells, donor4	11936-126A1	51.04	24.84	5.16	0.97	0.29	0.10	0.19	1.07
Oligodendrocyte - precursors, donor1	11496-119F2	49.95	30.69	3.61	4.81	0.00	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	39.56	13.83	8.51	0.43	0.43	0.00	0.00	0.85
Osteoblast - differentiated, donor2	11353-117H3	20.58	5.72	4.57	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	26.07	16.14	9.31	1.24	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	28.34	14.46	1.37	0.39	0.00	0.20	0.20	0.98
Osteoblast, donor2	11354-117H4	42.14	30.90	6.32	0.00	0.00	0.00	0.00	1.40
Osteoblast, donor3	11426-118G4	46.57	20.44	5.87	0.71	0.00	0.18	0.00	0.89
Pancreatic stromal cells, donor1	11249-116E7	52.23	20.22	16.34	1.35	0.25	0.34	0.34	0.67
Pericytes, donor1	11491-119E6	12.46	4.45	0.78	0.45	0.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	13.36	2.72	1.13	0.23	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	15.06	5.49	0.81	0.61	0.41	0.20	0.00	0.20
Perineurial Cells, donor1	11499-119F5	43.06	19.33	2.26	1.47	0.00	0.34	0.00	0.34
Perineurial Cells, donor2	11579-120F4	41.50	28.71	4.97	1.20	0.37	0.00	0.09	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	130.05	99.13	10.84	1.91	0.00	0.00	0.00	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	120.23	82.76	18.85	2.69	0.00	1.22	0.49	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	95.51	81.92	26.40	2.59	0.13	0.13	0.00	0.26
Placental Epithelial Cells, donor1	11278-116H9	20.09	15.07	6.46	1.91	0.00	0.00	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	22.18	5.54	0.00	2.22	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	19.63	17.28	1.96	1.77	0.00	0.00	0.00	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	25.95	10.44	1.58	0.95	0.32	0.00	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	31.89	14.07	2.81	1.31	0.19	0.00	0.00	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	23.10	11.09	1.04	1.04	0.26	0.13	0.00	0.78
Preadipocyte - breast, donor2	11328-117E5	31.75	14.63	2.48	0.45	0.45	0.23	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	36.12	11.93	2.66	0.96	0.85	0.11	0.00	0.64
Preadipocyte - omental, donor2	11329-117E6	32.30	20.51	5.67	2.18	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	30.51	13.61	4.01	1.29	0.14	0.00	0.43	0.43
Preadipocyte - perirenal, donor1	11469-119C2	15.75	3.94	0.98	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	24.26	10.75	3.99	1.54	0.31	0.31	0.00	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	57.02	29.75	10.27	1.24	0.35	0.18	0.53	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	41.55	15.84	10.05	0.85	0.34	0.51	0.00	0.51
Preadipocyte - visceral, donor1	11280-116I2	61.38	28.41	9.78	2.05	0.47	0.00	0.09	0.37
Preadipocyte - visceral, donor2	11357-117H7	48.32	31.29	8.28	1.38	0.00	0.46	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	38.66	19.54	7.31	1.04	0.00	0.10	0.00	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	42.99	44.20	15.09	6.18	0.30	0.75	0.00	0.15
Prostate Epithelial Cells, donor2	11331-117E8	23.43	15.44	2.57	1.90	0.00	0.00	0.00	0.41
Prostate Epithelial Cells, donor3	11404-118D9	36.13	22.90	0.92	1.10	0.31	0.00	0.00	0.37
Prostate Stromal Cells, donor1	11254-116F3	42.60	20.16	4.78	1.48	0.11	0.00	0.23	0.46
Prostate Stromal Cells, donor2	11332-117E9	45.36	19.90	6.10	1.26	0.72	0.36	0.18	0.36
Prostate Stromal Cells, donor3	11405-118E1	36.18	13.45	18.46	1.36	0.21	0.63	0.00	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	17.88	8.03	1.82	0.73	0.00	0.00	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	41.10	26.82	3.12	1.46	0.14	0.14	0.21	0.28
Renal Epithelial Cells, donor1	11517-119H5	12.68	7.61	0.00	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	19.21	9.25	1.42	0.71	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	49.02	32.39	2.65	2.75	0.32	0.21	0.00	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	11.57	6.81	2.04	0.68	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	17.25	9.84	1.62	1.35	0.00	0.00	0.00	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	49.73	35.30	3.77	2.22	0.44	0.22	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	2.66	0.00	0.67	0.00	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	16.07	9.46	1.54	0.22	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	16.93	11.91	1.88	0.63	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	10.82	5.27	1.11	0.28	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	24.43	20.13	1.88	1.07	0.27	0.00	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.92	14.34	1.27	0.84	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	19.28	17.16	1.35	0.77	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	35.00	22.56	4.15	1.30	0.00	0.00	0.00	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	18.76	13.93	1.99	0.85	0.00	0.00	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	16.47	10.29	2.06	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	35.38	37.13	1.51	1.00	0.00	0.00	0.00	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	72.43	35.01	9.89	5.21	0.27	0.00	0.13	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	75.94	50.03	6.25	2.68	0.89	0.00	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	77.05	47.33	2.75	3.85	0.00	0.55	0.55	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	110.21	52.20	3.48	5.22	0.00	0.00	0.58	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	66.05	59.16	7.80	5.72	0.39	0.00	0.39	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	65.44	47.37	7.94	3.77	0.60	0.00	0.50	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	68.49	59.00	7.92	4.02	0.56	0.11	0.22	1.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	77.40	51.73	10.05	4.59	0.25	0.37	0.12	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	64.68	47.55	8.39	3.50	0.12	0.12	0.47	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	69.57	43.92	7.63	4.16	1.62	0.23	0.23	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	57.78	46.28	4.11	4.65	0.41	0.27	0.14	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	57.18	44.02	7.71	2.12	0.30	0.30	0.45	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	75.44	48.20	6.63	3.23	0.00	0.00	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	56.09	47.77	6.74	3.44	0.43	0.00	0.14	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	56.66	40.46	6.65	3.11	0.21	0.00	0.11	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	54.87	39.16	4.65	3.76	0.44	0.00	0.00	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	60.03	51.24	3.44	4.21	0.38	0.19	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	61.67	46.58	9.13	3.54	0.19	0.28	0.09	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	77.61	56.75	7.14	3.38	0.38	0.19	0.00	1.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	56.80	55.34	7.30	4.91	0.13	0.27	0.13	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	67.55	53.15	7.30	4.48	0.68	0.00	0.19	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	57.10	48.89	6.30	3.82	0.38	0.19	0.00	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	56.49	52.97	5.77	4.06	0.43	0.11	0.21	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	55.78	47.65	5.61	2.80	0.84	0.28	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	66.65	49.73	9.23	3.93	0.68	0.00	0.00	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	51.23	56.34	5.11	4.38	0.00	0.18	0.36	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	56.29	48.56	6.13	2.82	0.00	0.00	0.12	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	62.59	49.03	8.19	3.49	0.13	0.40	0.27	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	66.52	55.90	2.83	2.59	0.00	0.24	0.47	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	56.75	57.94	7.14	3.37	0.60	0.60	0.40	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	48.64	52.38	8.42	3.51	0.94	0.00	0.23	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	60.76	62.41	4.98	4.56	0.41	0.62	0.21	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	54.20	60.39	5.09	4.65	0.44	1.33	0.22	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	71.65	55.77	6.68	2.92	0.21	0.00	0.21	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	62.31	62.85	5.65	4.04	0.27	0.00	0.27	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	67.95	65.73	7.83	2.72	0.34	0.34	0.00	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	68.63	58.22	8.29	4.82	0.39	0.19	0.19	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	54.50	47.63	4.30	2.41	0.52	0.17	0.00	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	73.80	53.91	8.23	3.02	0.69	0.14	0.00	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	69.77	45.31	8.37	2.96	0.00	0.33	0.82	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	50.79	46.53	5.62	2.22	0.34	0.00	0.34	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	66.43	47.20	8.73	2.66	0.30	0.30	0.15	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	59.71	37.05	8.00	3.47	0.00	0.00	0.27	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	51.99	47.84	5.53	1.80	0.69	0.00	0.00	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	61.19	40.95	6.43	1.67	0.48	0.71	0.00	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	71.95	46.76	8.06	3.63	0.40	0.20	0.00	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	44.26	45.11	5.93	2.45	0.38	0.09	0.09	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	61.49	51.71	2.79	4.54	1.05	0.35	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	71.02	52.89	8.46	4.84	1.81	0.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	45.16	41.12	5.39	2.94	0.00	0.12	0.12	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	107.71	93.59	8.59	6.40	0.87	0.15	0.15	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	68.14	43.81	8.52	1.83	0.61	0.00	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	47.62	43.10	7.23	3.01	0.60	0.00	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	59.04	45.69	7.92	2.71	0.23	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	73.39	43.13	8.39	1.80	0.60	0.30	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	52.19	43.81	5.08	3.42	0.12	0.00	0.12	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	71.08	56.35	4.91	3.42	0.21	0.00	0.43	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	76.32	48.08	3.61	3.00	0.00	0.00	0.60	0.60
Schwann Cells, donor1	11498-119F4	14.67	7.90	2.44	0.56	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	40.83	37.43	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	37.68	17.31	3.07	0.66	0.44	0.22	0.00	0.44
Sebocyte, donor1	11220-116B5	42.73	32.32	8.22	5.48	0.00	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	28.03	22.06	2.76	2.76	0.00	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	38.13	12.78	24.73	3.71	0.41	0.00	0.21	0.00
Sertoli Cells, donor1	11255-116F4	53.01	19.88	8.28	3.31	0.00	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	33.89	2.82	0.00	0.00	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	65.10	35.19	19.18	4.05	0.53	0.18	0.18	1.50
Skeletal Muscle Cells, donor2	11358-117H8	11.57	11.57	5.06	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	20.06	19.23	0.84	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	35.35	31.26	5.18	2.20	0.31	0.00	0.16	0.63
Skeletal Muscle Cells, donor5	11455-119A6	27.80	30.32	4.61	1.93	0.45	0.15	0.15	0.00
Skeletal Muscle Cells, donor6	11459-119B1	44.63	35.24	10.77	3.23	0.46	0.00	0.15	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	60.61	34.65	16.25	2.27	0.63	0.25	0.13	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	51.51	25.97	14.55	1.71	0.00	0.43	0.00	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	52.09	31.45	17.86	3.17	0.10	0.30	0.10	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	37.91	21.40	2.61	1.43	0.25	0.08	0.08	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	39.08	18.82	0.72	1.45	0.72	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	17.20	13.35	4.13	0.28	0.14	0.00	0.00	0.28
Skin - palm, donor1	10286-104F7	182.66	75.21	18.80	10.74	0.00	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	23.79	13.69	1.59	2.16	0.00	0.00	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	72.79	58.07	1.64	4.09	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	21.16	22.20	1.95	1.43	0.13	0.00	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	37.81	36.28	3.48	3.61	0.00	0.14	0.14	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	44.17	41.35	4.36	3.52	0.28	0.14	0.14	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	56.46	50.11	7.40	3.17	0.00	0.00	0.00	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	42.12	34.63	3.45	4.12	0.22	0.07	0.07	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	36.10	15.12	3.09	0.62	0.00	0.62	0.31	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	15.12	9.34	2.22	0.22	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	26.45	22.34	5.88	0.59	0.00	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	45.52	9.28	15.91	0.88	0.00	0.00	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.21	7.09	5.12	0.39	0.00	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.04	17.00	9.27	2.32	0.00	0.00	0.00	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	25.02	20.02	1.00	0.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	30.74	9.85	5.86	1.73	0.27	0.00	0.00	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	50.98	15.74	11.53	1.11	0.89	0.44	0.00	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	32.65	16.26	10.37	2.69	0.38	0.13	0.13	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	35.16	20.19	3.26	0.65	0.00	0.00	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	34.55	15.06	3.54	2.07	0.59	0.00	0.00	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	30.18	11.82	7.55	0.85	0.00	0.00	0.14	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	11.39	4.72	1.63	0.65	0.16	0.00	0.00	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	58.15	15.22	4.26	0.00	0.91	0.30	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	42.68	13.64	8.33	1.01	0.51	0.00	0.00	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	55.09	0.00	12.24	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.03	13.83	9.54	1.91	0.00	0.00	1.43	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	35.98	17.40	3.24	1.18	0.44	0.15	0.00	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	35.94	17.65	3.87	0.86	0.00	0.22	0.43	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	33.06	20.68	6.19	1.26	0.10	0.10	0.00	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	17.79	10.36	3.87	0.93	0.00	0.00	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	10.78	5.39	4.31	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	19.72	13.15	8.67	2.69	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	13.31	6.83	2.39	0.34	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	41.78	24.97	2.75	1.96	0.08	0.24	0.08	0.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	40.96	12.08	2.31	0.70	0.70	0.00	0.00	1.31
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	75.09	22.76	69.40	4.32	0.23	1.14	0.23	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	10.87	9.66	3.62	0.60	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	56.16	42.12	7.42	1.85	0.26	0.79	0.26	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	36.75	19.17	4.79	0.67	0.40	0.27	0.13	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	34.81	19.53	7.01	1.25	0.38	0.00	0.00	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	32.22	11.16	16.74	0.51	0.51	0.00	0.25	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	35.43	15.23	3.32	0.75	0.45	0.00	0.00	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	22.51	9.75	3.00	0.75	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	111.13	7.75	2.58	0.00	2.58	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	28.37	11.16	4.19	1.86	0.00	0.00	0.00	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	25.24	18.18	12.62	2.52	0.50	0.00	0.00	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	33.22	16.92	15.67	1.57	0.31	0.63	0.31	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.49	3.54	1.77	0.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	64.23	39.32	4.25	1.50	0.58	0.25	0.08	0.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	39.71	18.69	1.87	0.93	0.00	0.00	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	28.35	11.37	5.47	1.30	0.00	0.00	0.00	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	31.87	23.71	10.45	1.53	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	19.74	9.78	1.69	0.94	0.19	0.00	0.56	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	41.36	21.24	3.77	1.40	0.14	0.00	0.00	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	43.57	19.44	7.21	1.68	0.00	0.08	0.08	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.00	4.29	10.48	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	23.24	12.72	3.67	0.98	0.49	0.00	0.24	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	33.36	16.13	8.18	1.10	0.44	0.00	0.00	1.33
Smooth Muscle Cells - Uterine, donor3	11466-119B8	32.77	18.14	3.51	0.88	1.17	0.00	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	41.59	10.69	2.33	0.58	0.00	0.19	0.19	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	32.26	13.49	2.12	1.06	0.53	0.53	0.00	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	49.47	6.70	1.86	0.37	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	40.96	8.62	3.59	0.00	0.00	0.00	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	28.11	14.48	3.41	1.14	0.28	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	43.33	27.96	2.76	1.18	0.00	0.39	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	51.55	12.44	9.90	0.76	0.51	0.00	1.02	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	59.10	14.38	13.98	0.40	0.00	0.00	1.20	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	34.28	12.12	9.20	2.09	0.42	0.00	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	40.79	14.21	5.04	0.92	0.46	0.00	0.00	0.92
Synoviocyte, donor1	11291-117A4	52.68	15.15	15.49	1.68	1.01	0.34	0.00	1.01
Synoviocyte, donor2	11368-117I9	62.86	20.28	57.16	2.18	0.34	0.34	0.34	0.17
Synoviocyte, donor3	11440-118H9	47.59	16.53	51.38	1.79	0.22	0.45	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	16.08	9.65	1.07	0.36	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	13.87	3.96	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	17.83	11.81	0.46	0.23	0.00	0.00	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	31.40	22.37	1.08	1.94	0.14	0.14	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	16.62	18.94	1.16	0.77	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	18.33	26.92	1.15	2.86	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	69.14	36.91	11.20	3.57	0.74	0.12	0.00	0.86
Urethra, donor2	10319-105A4	109.70	57.55	3.60	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	11.95	6.11	0.53	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	7.21	4.01	0.00	0.40	0.00	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	9.86	4.13	0.46	0.23	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	46.36	22.96	0.89	1.11	0.22	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	122.79	58.73	2.67	5.34	0.00	0.00	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	124.38	81.49	8.58	7.15	0.00	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	95.83	43.12	2.05	1.37	0.00	0.68	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	118.11	59.23	3.44	5.51	0.00	0.00	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	122.02	72.05	5.81	3.49	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	86.42	69.76	5.21	4.16	0.00	1.04	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	131.24	67.92	8.26	5.51	0.00	1.84	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	96.77	46.56	1.83	0.91	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	46.75	47.37	8.51	3.70	0.00	0.00	0.12	0.86
Wilms' tumor cell line:HFWT	10597-108E3	53.68	56.32	2.64	6.16	0.00	0.00	0.00	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	42.18	38.27	9.50	2.79	0.56	0.00	0.00	0.28
achilles tendon, donor2	10292-104G4	97.13	55.80	35.13	8.27	0.00	0.00	0.00	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	22.44	31.61	6.88	1.27	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	80.80	105.18	10.91	8.36	0.93	0.00	0.70	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	94.61	113.13	11.99	4.15	0.12	0.24	0.24	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	74.56	78.64	15.51	6.80	0.54	0.54	0.27	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	57.34	53.41	3.65	2.81	0.00	0.00	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	70.00	69.79	8.46	4.44	0.21	0.21	0.21	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	53.63	64.51	8.71	3.27	0.54	0.00	0.27	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	46.71	55.08	3.97	3.97	0.88	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	58.40	56.35	8.58	4.49	0.41	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	59.41	90.47	8.15	5.05	0.00	0.00	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	51.15	56.49	4.23	2.39	0.18	0.18	0.18	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	120.92	7.80	23.40	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	31.37	36.95	4.18	1.63	0.00	0.00	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	107.96	114.43	11.65	4.14	0.00	0.00	0.26	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	104.92	93.52	7.31	3.80	0.00	0.58	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	63.67	70.64	2.79	3.72	0.46	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	41.95	55.93	3.70	3.29	0.00	0.41	0.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	41.13	81.03	5.53	4.60	0.00	0.00	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	91.74	72.11	8.53	2.99	0.00	0.00	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	94.02	66.42	5.46	3.03	0.61	0.00	0.00	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	96.04	72.45	8.91	3.13	0.00	0.00	0.00	1.93
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	37.42	43.21	2.45	1.78	0.00	0.00	0.00	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	48.36	96.06	2.67	4.67	0.33	0.00	0.00	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	262.01	228.56	16.72	22.30	0.00	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	52.73	51.60	5.27	5.65	0.00	0.00	0.75	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	72.83	116.01	13.52	9.16	0.00	0.00	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	91.85	148.08	18.74	16.87	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	60.52	83.84	4.47	4.95	0.00	0.00	0.00	0.71
adipose tissue, adult, pool1	10010-101C1	80.04	38.78	12.87	4.03	0.93	0.16	0.31	1.55
adipose, donor1	10184-103D4	153.05	90.31	22.28	5.28	0.00	0.00	0.00	0.00
adipose, donor2	10185-103D5	36.09	34.87	4.06	1.62	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	54.46	43.02	7.62	2.18	0.00	0.27	0.54	0.00
adipose, donor4	10187-103D7	116.14	45.07	15.60	5.20	0.00	1.73	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	63.76	39.93	9.00	1.26	0.16	0.00	0.00	0.47
adrenal gland, adult, pool1	10081-102A9	21.83	21.83	3.64	7.28	3.64	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	52.83	45.62	5.60	3.34	0.53	0.27	0.00	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	71.10	58.60	8.93	4.29	0.00	0.00	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	48.22	60.05	9.51	6.03	0.23	0.00	0.00	0.93
amniotic membrane cells, donor2	12236-129G4	72.35	33.13	10.14	0.68	0.00	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	68.94	27.40	6.78	3.54	0.29	0.29	0.00	0.59
amygdala - adult, donor10196	10167-103B5	98.42	35.57	4.74	3.56	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	73.81	28.18	7.71	2.43	1.62	0.00	0.20	1.62
amygdala, newborn, donor10223	10360-105E9	47.12	21.63	9.68	0.97	0.32	0.00	0.00	2.26
anaplastic carcinoma cell line:8305C	10428-106D5	28.14	20.25	7.51	3.82	0.00	0.00	0.13	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	58.47	79.20	16.55	7.06	0.22	0.44	0.66	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	77.16	108.23	36.41	8.35	0.00	0.00	0.00	0.67
aorta, adult, pool1	10052-101G7	65.90	22.36	6.86	2.35	0.20	0.20	0.00	0.98
appendix, adult	10189-103D9	95.09	85.00	10.87	10.09	0.39	0.00	0.39	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	53.31	76.35	4.47	4.82	0.00	0.00	0.34	0.34
artery, adult	10190-103E1	51.63	31.25	5.43	4.08	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	73.59	72.87	10.00	6.08	0.14	0.14	0.00	1.16
b cell line:RPMI1788	10427-106D4	56.80	43.42	7.29	1.64	0.30	0.15	0.15	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	29.41	12.49	4.44	0.28	0.28	0.00	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	31.85	35.43	3.27	2.68	0.30	0.00	0.10	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	77.33	85.70	6.70	9.21	0.17	0.33	0.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	41.38	70.46	3.91	2.80	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	83.55	28.57	8.26	2.72	0.22	0.11	0.11	1.41
blood, adult, pool1	10053-101G8	53.15	37.65	2.21	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	60.80	35.97	6.85	1.71	0.00	0.00	0.00	0.86
bone marrow, adult	10192-103E3	56.01	33.07	2.70	2.70	2.02	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	44.08	27.68	4.10	1.03	1.03	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	63.14	25.17	5.57	1.22	0.56	0.11	0.00	0.78
brain, fetal, pool1	10085-102B4	56.10	56.10	5.34	0.00	2.67	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	38.65	37.99	3.96	0.99	0.66	0.00	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	90.25	38.82	6.74	2.12	0.50	0.12	0.12	1.62
breast, adult, donor1	10080-102A8	62.50	33.46	5.05	9.47	0.00	0.00	0.00	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	56.66	68.85	7.62	6.99	0.13	0.13	0.00	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	40.51	40.51	3.40	2.78	0.00	0.00	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	34.07	18.42	0.92	0.00	0.00	0.23	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	37.52	37.52	9.68	2.42	0.00	0.00	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	63.94	45.14	4.70	4.23	0.00	0.47	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	42.88	46.60	3.83	4.38	0.00	0.11	0.22	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	43.41	38.66	0.63	2.54	0.00	0.00	0.32	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	87.57	80.39	6.12	7.72	0.00	0.27	0.27	2.13
caudate nucleus - adult, donor10196	10177-103C6	90.95	39.14	12.66	0.00	2.30	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	78.14	30.79	9.37	3.18	0.33	0.00	0.00	2.01
caudate nucleus, adult, donor10258	10379-105H1	53.49	34.39	4.58	0.76	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	52.74	26.74	19.41	5.13	0.00	0.37	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	227.24	72.83	5.83	5.83	2.91	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	137.50	60.42	7.47	7.26	0.64	0.43	0.21	1.07
cerebellum, adult, pool1	10083-102B2	67.95	35.18	3.45	2.41	0.00	0.34	0.00	1.03
cerebellum, newborn, donor10223	10357-105E6	110.43	41.51	3.32	3.32	0.00	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	80.68	40.34	4.79	2.02	0.00	0.00	0.25	1.26
cerebrospinal fluid, donor2	10294-104G6	43.85	43.12	40.20	5.12	0.00	0.00	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	36.38	35.51	3.02	3.31	0.14	0.29	0.14	0.58
cervical cancer cell line:ME-180	10553-107I4	42.59	39.61	6.63	4.31	0.17	0.00	0.17	0.50
cervix, adult, pool1	10013-101C4	95.54	38.53	6.61	1.78	1.47	0.10	0.10	3.04
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	41.10	21.32	59.08	4.74	0.00	0.28	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	74.46	40.49	13.06	2.61	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	51.70	46.11	6.21	3.73	0.25	0.25	0.25	0.25
choriocarcinoma cell line:SCH	10785-110H2	68.51	90.93	10.10	5.17	0.12	0.25	0.12	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	83.96	111.95	4.27	7.12	0.47	0.00	0.00	0.47
chorionic membrane cells, donor1	12238-129G6	46.73	49.29	10.54	5.13	0.00	0.28	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	55.68	27.14	5.47	1.49	0.50	0.20	0.10	0.40
chorionic membrane cells, donor3	12240-129G8	80.22	46.16	11.54	2.75	0.00	0.00	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	37.36	39.38	6.06	5.05	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	64.35	69.54	8.26	3.84	0.19	0.00	0.38	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	88.06	84.47	11.83	6.12	0.00	0.00	0.42	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	82.43	54.18	1.54	2.31	0.00	0.26	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	81.75	71.35	2.42	4.11	0.00	0.00	0.00	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	82.46	60.68	2.85	3.46	0.00	0.20	0.00	1.43
chronic myelogenous leukemia cell line:K562	10454-106G4	63.60	81.27	6.48	4.12	0.29	0.59	0.00	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	128.49	148.82	13.55	6.52	0.78	0.00	0.26	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	47.54	46.63	3.66	6.40	0.69	0.23	0.00	0.23
clear cell carcinoma cell line:TEN	10636-108I6	38.34	37.65	13.88	3.12	0.00	0.00	0.00	0.52
colon carcinoma cell line:CACO-2	10513-107D9	46.68	70.47	16.47	3.66	0.00	0.00	0.18	0.55
colon carcinoma cell line:COLO-320	10420-106C6	58.91	43.33	4.56	0.76	0.38	0.38	0.00	0.76
colon, adult, donor1	10082-102B1	44.03	47.60	4.76	2.38	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	73.32	44.65	6.35	2.94	0.94	0.00	0.12	1.06
colon, fetal, donor1	10070-101I7	63.03	53.15	2.47	4.33	0.62	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	165.01	302.51	32.08	13.75	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	75.11	0.00	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	81.59	113.88	22.52	12.32	0.42	0.00	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	56.60	65.05	7.85	4.38	0.30	0.15	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	56.69	67.69	6.35	4.23	0.14	0.00	0.00	0.28
corpus callosum, adult, pool1	10042-101F6	67.89	31.73	4.98	2.21	1.55	0.11	0.11	2.54
cruciate ligament, donor2	10295-104G7	108.60	37.28	51.06	4.86	0.00	0.00	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	44.94	36.92	3.21	5.62	0.00	0.00	0.00	2.41
diencephalon, adult	10193-103E4	46.08	23.52	3.84	1.44	0.24	0.24	0.24	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	65.90	73.93	8.50	3.90	0.00	1.38	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	67.70	67.19	2.82	4.36	0.51	0.51	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	36.59	34.18	5.78	2.41	0.00	0.24	0.00	0.24
ductus deferens, adult	10196-103E7	69.27	31.89	4.49	0.50	1.50	0.00	0.00	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	63.37	57.61	4.32	0.00	2.88	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	67.68	43.40	1.47	2.94	0.00	0.00	0.00	2.21
dura mater, adult, donor1	10041-101F5	105.71	41.05	41.62	1.16	0.17	0.17	0.00	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	51.74	109.48	19.76	16.43	0.22	0.00	0.22	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	50.30	70.93	3.30	5.02	0.14	0.00	0.14	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	73.38	41.93	2.47	5.55	0.00	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	37.23	25.43	2.42	2.72	0.00	0.00	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	61.13	60.82	1.85	4.63	0.00	0.00	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	93.26	74.87	5.25	9.19	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	79.78	50.95	12.40	4.02	0.00	0.00	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	66.69	32.26	4.53	3.08	1.09	0.36	0.36	1.45
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	34.25	26.37	2.89	2.41	0.16	0.16	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	71.81	44.02	12.45	3.45	0.11	0.00	0.00	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	31.79	37.62	6.71	5.06	0.00	0.11	0.00	0.33
epididymis, adult	10197-103E8	66.98	34.33	4.19	1.05	0.84	0.00	0.21	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	53.05	51.09	1.77	2.48	0.18	0.18	0.00	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	38.14	46.40	4.72	1.57	0.39	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	22.28	35.51	7.99	4.46	0.13	0.00	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	29.23	47.44	9.25	4.53	0.00	0.10	0.20	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	26.89	37.08	8.51	3.70	0.00	0.45	0.00	0.22
esophagus, adult, pool1	10015-101C6	67.74	29.20	5.31	2.44	0.00	0.21	0.00	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	85.54	55.48	5.26	1.00	0.13	0.00	0.25	1.00
eye - muscle inferior rectus, donor1	10272-104E2	86.92	48.29	14.49	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	58.92	31.56	14.73	8.42	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	71.43	38.69	7.44	8.93	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	63.06	36.69	14.90	4.59	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	71.41	21.86	29.15	7.29	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	47.29	31.02	4.83	3.05	0.25	0.51	0.00	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	36.16	43.98	6.67	2.95	0.13	0.13	0.13	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	55.32	62.92	8.31	5.46	0.00	0.00	0.00	0.47
frontal lobe, adult, pool1	10040-101F4	71.12	28.99	3.28	1.97	0.47	0.09	0.00	1.41
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	85.57	80.17	12.61	6.31	0.00	0.30	0.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	56.42	30.54	5.58	3.38	0.18	0.00	0.00	0.27
gall bladder, adult	10198-103E9	57.70	27.52	3.86	1.69	0.72	0.24	0.24	2.66
gamma delta positive T cells, donor1	11937-126A2	118.11	70.33	4.83	4.29	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	111.30	73.58	6.72	4.11	0.00	0.37	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	30.63	33.16	6.55	2.53	0.21	0.42	0.42	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	33.85	47.97	3.09	4.06	0.00	0.39	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	62.14	73.29	3.93	3.28	0.49	0.16	0.33	0.33
gastric cancer cell line:GSS	10560-108A2	64.98	63.15	2.75	0.92	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	50.72	35.18	12.34	7.08	0.00	0.23	0.23	0.00
giant cell carcinoma cell line:LU65	10487-107B1	41.77	40.85	1.95	4.70	0.23	0.11	0.00	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	63.68	46.75	2.80	1.40	0.14	0.00	0.14	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	41.90	45.64	5.74	3.74	0.00	0.00	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	38.10	25.86	7.71	1.48	0.11	0.00	0.00	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	39.46	29.21	11.66	1.69	0.28	0.00	0.28	0.56
glioblastoma cell line:T98G	10485-107A8	41.39	23.40	3.75	1.66	0.00	0.11	0.00	0.33
glioma cell line:GI-1	10413-106B8	31.05	26.07	10.84	2.05	0.00	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	95.49	33.53	11.66	2.19	0.00	0.00	0.00	4.37
globus pallidus, adult, donor10252	10161-103A8	79.57	34.66	14.16	6.10	1.46	0.00	0.24	2.93
globus pallidus, adult, donor10258	10367-105F7	36.97	21.91	1.37	1.37	1.37	1.37	0.00	2.74
globus pallidus, newborn, donor10223	10364-105F4	33.57	22.38	15.45	3.20	0.00	0.00	0.00	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	105.23	293.66	12.24	7.34	0.00	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	21.86	21.86	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	36.59	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	40.00	23.36	3.84	2.24	0.64	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	79.43	43.62	6.89	5.51	0.00	0.00	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	55.79	48.47	3.66	4.12	0.46	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	61.83	59.26	7.09	4.51	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	54.62	104.92	7.19	7.19	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	41.15	59.67	9.60	6.17	0.00	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	61.79	35.31	5.52	7.72	1.10	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	35.92	56.61	3.74	2.01	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	77.73	23.62	9.57	2.69	0.00	0.30	0.00	1.49
heart - pulmonic valve, adult	10206-103F8	65.37	25.62	1.83	3.14	0.00	0.26	0.00	1.57
heart - tricuspid valve, adult	10207-103F9	103.25	55.79	90.76	7.49	0.83	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	47.55	32.65	7.35	3.88	0.20	0.61	0.61	0.20
heart, adult, diseased, donor1	10051-101G6	41.73	23.85	2.55	3.41	0.00	0.85	0.43	0.43
heart, adult, pool1	10016-101C7	71.75	31.74	7.13	1.61	0.46	0.00	0.00	0.23
heart, fetal, pool1	10046-101G1	77.11	43.13	6.16	4.00	1.13	0.00	0.00	1.95
hepatic mesenchymal tumor cell line:LI90	10778-110G4	50.60	18.20	3.39	0.93	0.93	0.00	0.31	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	145.08	167.67	14.27	14.27	0.00	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	80.66	105.74	20.22	6.96	0.11	0.22	0.11	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	84.23	106.93	20.15	7.04	0.00	0.49	0.61	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	85.90	102.97	19.40	6.77	0.10	0.10	0.20	0.71
hepatoma cell line:Li-7	10484-107A7	52.61	69.18	7.23	5.23	0.11	0.33	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	36.28	48.74	8.04	2.01	0.00	0.00	0.10	0.30
hippocampus - adult, donor10196	10169-103B7	88.01	31.23	9.46	3.79	1.89	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	75.52	26.94	9.18	3.47	1.84	0.20	0.20	2.25
hippocampus, adult, donor10258	10374-105G5	55.27	30.87	1.00	1.99	0.00	0.00	0.00	2.49
hippocampus, newborn, donor10223	10363-105F3	38.77	26.08	15.16	3.17	1.06	0.00	0.00	2.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	126.95	81.79	15.26	7.32	0.00	0.00	1.22	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	55.37	51.05	7.46	3.53	0.00	0.39	0.59	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	70.33	46.21	7.36	5.84	0.00	0.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	57.51	53.00	11.28	2.82	1.13	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	55.00	51.38	8.26	3.61	0.00	1.81	0.26	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	72.13	54.66	5.31	1.52	0.00	0.38	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	62.19	57.81	9.63	3.80	0.29	0.88	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	51.06	48.69	7.54	5.82	0.00	0.22	0.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	60.06	48.80	6.67	5.42	0.42	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	55.41	66.78	6.16	4.97	0.24	0.00	0.24	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	44.36	61.55	6.43	6.75	0.00	0.00	0.48	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	52.52	77.43	8.75	6.73	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	38.65	39.12	8.61	5.63	0.16	0.16	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	38.32	46.18	8.35	3.93	0.49	0.98	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	67.20	59.35	7.85	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	61.47	61.86	5.15	2.10	0.19	0.57	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	51.02	62.79	3.92	5.23	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	90.96	63.47	4.50	3.00	0.00	1.00	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	44.84	30.71	2.45	1.51	0.00	0.00	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	51.38	35.47	4.09	2.27	0.00	0.45	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	49.18	30.38	2.19	2.51	0.00	0.00	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	49.97	45.23	3.59	3.10	0.00	0.00	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	45.29	40.35	3.48	2.90	0.00	0.00	0.29	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	40.06	42.15	5.98	2.69	0.30	0.00	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	48.03	39.54	7.76	5.54	0.18	0.37	0.37	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	45.07	44.50	10.84	3.42	0.00	0.57	0.86	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	84.93	59.21	13.47	4.90	0.41	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	59.50	52.81	9.51	2.46	0.35	0.70	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	55.43	52.90	5.38	4.12	0.00	0.00	0.00	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	59.01	47.81	5.14	1.82	0.30	0.61	0.30	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	48.09	42.40	3.10	2.07	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	49.81	28.56	1.99	2.66	0.00	0.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	47.20	39.25	3.33	1.80	0.00	0.00	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	46.02	43.20	3.32	3.83	0.26	0.26	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	49.98	62.09	4.54	3.79	0.00	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	46.71	40.33	4.37	4.37	0.34	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	47.58	45.40	10.87	3.86	0.24	0.48	0.24	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	61.95	48.58	6.68	2.23	0.00	0.00	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	59.02	41.95	9.76	2.93	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	56.54	59.29	8.25	3.36	0.00	0.31	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	393.64	253.75	42.29	13.01	0.00	6.51	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	76.78	57.58	10.59	4.30	0.00	0.33	0.00	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	54.18	37.22	4.38	2.74	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	49.94	40.53	3.98	3.98	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	51.25	41.99	4.27	2.85	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	22.67	39.38	3.58	7.16	0.00	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	60.81	55.93	7.31	4.06	0.81	0.41	0.00	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	42.30	40.95	3.77	3.50	0.00	0.27	0.00	0.54
immature langerhans cells, donor1	11904-125F5	137.05	115.02	50.61	8.96	0.00	0.24	0.48	0.24
immature langerhans cells, donor2	11905-125F6	66.54	46.74	45.15	3.17	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	71.73	31.42	4.45	1.61	0.76	0.09	0.00	1.61
keratoacanthoma cell line:HKA-1	10791-110H8	34.47	27.31	3.25	2.93	0.00	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	59.88	40.75	13.62	2.50	0.20	0.00	0.10	1.00
kidney, fetal, pool1	10045-101F9	76.32	34.31	8.77	1.98	0.71	0.07	0.00	2.48
large cell lung carcinoma cell line:IA-LM	10509-107D5	30.96	35.08	2.84	2.56	0.28	0.00	0.00	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	12.86	14.52	6.77	1.38	0.14	0.14	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	50.83	60.55	8.81	7.34	0.73	0.37	0.00	0.55
left atrium, adult, donor1	10079-102A7	43.59	20.70	2.72	1.63	0.00	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	39.95	30.84	5.06	2.53	0.51	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	60.47	62.38	21.89	3.56	0.27	0.00	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	25.87	9.70	8.62	0.72	0.00	1.08	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	15.22	6.52	3.26	0.54	1.09	0.54	0.00	0.54
leiomyoma cell line:15425	10571-108B4	32.54	10.93	1.94	0.73	0.00	0.00	0.00	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	31.75	6.35	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	59.60	63.78	6.27	4.18	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	64.34	80.04	7.91	7.08	0.12	0.00	0.12	0.83
liposarcoma cell line:KMLS-1	10782-110G8	23.43	23.59	5.47	0.78	0.00	0.16	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	24.12	22.05	10.72	1.83	0.12	0.00	0.00	0.24
liver, adult, pool1	10018-101C9	44.57	35.17	6.48	3.24	0.16	0.32	0.49	0.49
liver, fetal, pool1	10086-102B5	31.98	18.81	4.70	0.94	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	67.23	33.25	8.46	4.37	1.31	0.29	0.44	1.31
locus coeruleus, adult, donor10252	10165-103B3	68.65	28.05	9.97	3.14	0.55	0.55	0.18	1.11
locus coeruleus, adult, donor10258	10375-105G6	28.50	24.26	4.23	3.10	0.85	0.00	0.00	1.13
locus coeruleus, newborn, donor10223	10362-105F2	57.62	25.66	33.23	2.10	1.26	1.68	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	22.70	36.95	3.04	2.08	0.00	0.00	0.00	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	34.47	28.27	1.38	0.69	0.00	0.00	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	81.33	50.75	3.03	2.77	0.13	0.26	0.13	0.13
lung, adult, pool1	10019-101D1	80.09	37.92	8.51	2.36	0.83	0.00	0.12	1.06
lung, fetal, donor1	10068-101I5	119.30	53.09	13.41	6.85	1.43	0.00	0.00	4.00
lung, right lower lobe, adult, donor1	10075-102A3	48.57	53.15	5.04	6.87	0.00	0.46	0.46	0.46
lymph node, adult, donor1	10077-102A5	62.01	36.92	11.83	2.37	0.47	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	45.37	50.41	5.04	3.29	0.66	0.22	0.00	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	51.32	97.95	12.38	4.98	0.15	0.15	0.30	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	133.37	115.53	16.99	15.29	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	87.02	40.85	68.82	3.55	1.33	0.00	0.00	1.78
mature adipocyte, donor2	12232-129F9	64.96	29.68	43.79	6.43	0.83	0.00	0.62	2.08
mature adipocyte, donor3	12233-129G1	85.11	28.21	98.38	5.93	1.19	0.00	0.24	1.19
mature adipocyte, donor4	12234-129G2	83.44	35.80	48.43	3.69	1.05	0.00	0.26	1.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	85.77	68.38	5.48	5.24	0.24	0.00	0.00	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	101.52	25.94	3.38	1.13	1.13	1.13	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	72.28	29.61	7.54	3.49	0.37	0.18	0.00	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	57.82	34.63	1.91	2.54	0.00	0.00	0.00	3.49
medial frontal gyrus, newborn, donor10223	10352-105E1	120.70	29.85	14.93	5.12	1.71	0.85	0.00	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	91.29	34.76	4.89	2.03	1.52	1.35	1.01	2.19
medial temporal gyrus, adult, donor10252	10156-103A3	65.37	28.23	7.22	4.03	0.64	0.21	0.00	2.76
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	42.38	38.53	3.85	1.93	0.00	0.00	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	215.30	57.41	28.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	52.76	17.23	4.67	1.44	1.44	0.00	0.00	2.15
medulla oblongata - adult, donor10196	10174-103C3	70.09	40.89	9.73	5.19	0.65	0.65	0.00	1.95
medulla oblongata, adult, donor10252	10155-103A2	67.03	26.78	10.06	4.49	0.93	0.00	0.00	1.70
medulla oblongata, adult, pool1	10038-101F2	57.14	28.49	6.53	3.02	0.90	0.00	0.00	1.39
medulla oblongata, newborn, donor10223	10361-105F1	47.22	26.39	11.11	3.47	0.35	0.00	0.00	1.74
medulloblastoma cell line:D283 Med	10838-111E1	99.64	47.16	3.10	4.43	0.89	0.44	0.22	0.66
medulloblastoma cell line:ONS-76	10759-110E3	34.36	45.49	5.99	3.42	0.00	0.12	0.00	0.37
melanoma cell line:COLO 679	10514-107E1	36.94	25.16	2.73	3.74	0.14	0.00	0.14	1.44
melanoma cell line:G-361	10465-106H6	22.80	13.30	1.36	0.54	0.27	0.00	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	32.02	19.72	2.53	1.45	0.18	0.36	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	102.21	119.84	13.22	9.69	0.00	0.88	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	108.61	90.99	8.04	6.22	0.52	0.26	0.26	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	35.90	15.96	3.99	1.38	0.46	0.31	0.00	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	36.17	12.36	7.63	0.91	0.36	0.18	0.18	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	29.82	10.77	6.63	0.41	0.83	0.00	0.00	2.07
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	43.69	13.20	28.24	2.25	0.28	0.56	0.00	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	44.87	15.21	24.07	2.31	0.58	1.16	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	49.28	19.43	23.60	0.69	0.00	0.00	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	46.86	17.51	36.56	2.23	0.34	0.34	0.17	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	37.04	12.77	13.00	1.38	0.12	0.46	0.23	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	34.62	12.20	7.03	0.93	0.13	0.40	0.00	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	46.18	23.36	35.79	2.57	0.00	0.54	0.14	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	44.95	20.91	21.05	0.71	0.28	0.00	0.00	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	72.46	20.75	86.62	4.61	0.00	0.66	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	39.99	17.57	15.77	1.94	0.14	0.55	0.14	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	32.12	10.47	3.49	1.05	0.70	0.00	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	29.20	7.55	2.65	0.41	0.20	0.00	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	30.55	11.50	9.35	1.08	0.00	0.36	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	29.28	13.45	16.35	1.45	0.21	0.10	0.10	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	28.04	9.35	11.86	0.91	0.00	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	38.18	21.82	7.13	4.20	0.00	0.42	0.42	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	35.27	11.96	18.08	1.20	0.75	0.60	0.30	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	39.91	21.97	13.30	2.98	0.09	0.00	0.18	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	42.34	13.99	4.79	1.84	0.00	0.37	0.00	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	34.63	11.45	10.59	0.86	0.29	0.29	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	42.52	36.63	5.05	2.53	0.42	0.42	0.84	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	29.68	20.55	2.74	0.91	0.46	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	29.93	19.18	4.09	0.51	0.00	0.00	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	34.03	16.23	2.36	0.79	0.26	0.00	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	36.35	16.33	2.77	0.00	0.31	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	36.48	16.95	4.00	1.18	0.24	0.00	0.00	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	34.52	17.60	3.05	1.35	0.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	34.58	17.68	3.54	1.18	0.00	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	41.70	14.83	4.17	0.46	0.46	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	42.69	19.32	2.02	0.29	0.29	0.29	0.29	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	31.68	19.19	4.02	0.45	0.00	0.67	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	43.98	18.27	5.29	1.44	0.48	0.00	0.00	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	47.67	22.73	7.33	0.00	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	34.91	14.77	3.02	1.01	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	38.48	18.01	2.05	0.82	0.00	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	35.22	15.89	6.01	1.72	0.00	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	49.22	27.34	0.00	0.00	0.00	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	10.33	10.33	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	34.10	11.04	3.25	1.30	0.32	0.00	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	30.55	20.37	5.82	0.00	0.00	0.00	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	31.45	19.72	4.26	2.13	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	31.89	14.72	9.81	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	31.49	17.49	8.16	1.17	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	16.79	8.39	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	35.76	22.85	2.98	0.99	0.00	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	28.60	9.53	4.77	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	29.06	21.94	7.12	0.59	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	21.93	6.09	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	81.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	34.84	16.47	4.43	1.90	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	25.87	17.59	4.14	1.03	0.00	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	15.04	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	43.91	7.98	11.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	44.77	30.99	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	32.19	14.67	7.33	2.04	0.00	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	32.57	15.09	4.77	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	38.32	15.33	2.36	1.18	0.59	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	34.29	16.52	6.86	1.87	0.62	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	37.43	12.03	9.36	1.34	1.34	0.00	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	29.57	11.83	8.28	3.55	0.00	0.00	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	43.66	20.54	0.00	10.27	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	43.37	15.83	11.01	0.69	0.00	0.69	0.00	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	22.27	12.37	2.47	0.99	0.99	0.00	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	25.79	12.34	3.36	2.24	1.12	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	27.99	12.72	5.72	1.27	0.64	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	23.37	11.28	1.61	0.81	0.40	0.00	0.00	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	23.99	8.72	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	15.20	6.34	2.53	3.80	1.27	0.00	0.00	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	34.59	18.81	2.43	3.03	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	9.04	9.04	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	29.65	18.94	0.82	5.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	29.96	12.10	3.77	1.19	0.40	0.00	0.40	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	29.20	11.36	3.89	0.00	0.00	0.00	0.00	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	28.52	8.15	4.07	0.00	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	64.22	14.70	6.19	0.00	0.77	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	87.88	40.87	3.31	3.31	0.00	0.00	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	58.85	45.41	12.28	4.87	0.00	0.23	0.46	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	34.19	8.55	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	35.55	29.08	13.67	2.67	0.00	0.41	0.10	0.41
mesothelioma cell line:Mero-25	10850-111F4	51.52	49.70	7.49	6.58	0.00	0.45	0.23	0.45
mesothelioma cell line:Mero-41	10851-111F5	38.87	32.27	2.20	2.20	0.00	0.00	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	47.39	38.75	4.43	4.43	0.00	0.00	0.00	0.66
mesothelioma cell line:Mero-82	10853-111F7	48.36	50.20	18.66	6.31	0.00	0.00	0.00	0.79
mesothelioma cell line:Mero-83	10854-111F8	15.49	17.19	5.11	1.19	0.17	0.17	0.00	0.34
mesothelioma cell line:Mero-84	10855-111F9	11.63	21.99	4.55	0.76	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	31.47	28.78	9.52	2.28	0.21	0.41	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	26.34	20.37	4.64	2.15	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	30.41	43.08	13.57	3.08	0.36	0.18	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	50.56	43.90	3.07	1.88	0.17	0.00	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	37.15	44.02	5.34	4.83	0.00	0.00	0.25	0.00
mesothelioma cell line:No36	10857-111G2	13.37	30.66	1.30	3.59	0.00	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	47.42	47.42	12.73	5.42	0.00	0.81	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	112.08	44.72	17.66	1.54	0.19	0.00	0.96	0.00
migratory langerhans cells, donor2	11902-125F3	74.61	33.34	8.30	1.83	0.12	0.12	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	80.77	57.43	7.54	2.33	0.00	0.18	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	64.32	43.75	5.88	6.86	0.00	1.63	0.98	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.27	25.64	10.81	2.76	0.21	0.42	0.00	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	63.12	73.94	7.37	9.44	0.00	0.00	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	26.45	32.35	4.95	2.66	0.38	0.00	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	58.95	62.83	7.02	5.73	0.18	0.00	0.55	1.11
myeloma cell line:PCM6	10474-106I6	53.77	50.80	3.36	4.74	0.00	0.20	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	49.21	28.92	8.62	3.04	0.00	0.00	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	76.10	55.31	36.87	7.45	0.20	0.00	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	44.57	42.34	1.34	3.01	0.11	0.00	0.33	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	45.23	31.84	0.59	2.72	0.07	0.00	0.07	0.66
nasal epithelial cells, donor2	12227-129F4	56.85	35.88	3.86	3.31	0.00	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	51.53	62.81	6.44	3.22	0.00	0.00	0.00	0.69
neuroblastoma cell line:NB-1	10539-107G8	81.76	76.52	5.43	4.49	0.56	0.00	0.19	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	24.25	26.78	1.69	2.32	0.00	0.00	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	76.03	65.97	8.76	4.66	0.56	0.37	0.37	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	64.53	50.05	3.32	2.85	0.47	0.71	0.71	1.66
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	57.49	32.15	3.33	2.22	0.79	0.00	0.16	2.22
neuroectodermal tumor cell line:TASK1	10774-110F9	39.25	54.54	4.03	3.42	0.81	0.00	0.20	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	85.83	68.03	7.63	1.27	2.54	0.00	0.00	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	32.47	24.22	6.39	1.60	0.27	0.00	0.00	1.06
neutrophil PMN, donor1	12133-128D9	193.37	535.49	59.50	29.75	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	106.25	79.68	66.40	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	208.35	104.18	104.18	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	166.92	114.33	17.93	3.72	0.17	0.17	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	16.01	13.61	1.60	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	34.63	15.07	6.41	1.60	0.32	0.32	0.32	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	36.00	19.18	3.42	0.79	0.79	0.00	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	64.12	28.78	3.84	1.50	0.56	0.09	0.00	1.87
occipital cortex - adult, donor10196	10172-103C1	105.08	49.45	2.06	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	83.19	35.96	12.34	5.64	1.07	0.00	0.27	1.61
occipital cortex, newborn, donor10223	10355-105E4	56.78	27.66	4.73	1.82	1.82	0.36	0.00	1.09
occipital lobe, adult, donor1	10076-102A4	53.79	33.85	3.15	3.94	0.52	0.26	1.05	1.05
occipital lobe, fetal, donor1	10073-102A1	110.71	83.25	6.44	4.29	3.43	0.00	0.00	4.29
occipital pole, adult, pool1	10036-101E9	48.96	26.73	3.23	0.87	1.02	0.08	0.00	0.87
olfactory region, adult	10195-103E6	54.45	25.98	4.59	1.53	0.76	0.00	0.19	2.10
optic nerve, donor1	10277-104E7	64.03	46.02	14.01	2.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	55.02	44.42	7.40	4.33	0.34	0.11	0.00	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	69.24	43.55	6.87	1.79	0.14	0.00	0.14	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	33.19	28.11	4.06	2.03	0.17	0.17	0.17	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	57.52	54.87	9.59	4.39	0.23	0.00	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	27.93	26.46	3.23	2.65	0.29	0.00	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	96.24	79.42	5.61	10.28	1.87	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	31.60	22.05	9.75	1.27	0.64	0.00	0.00	1.27
ovary, adult, pool1	10020-101D2	83.42	45.60	6.29	3.84	1.48	0.35	0.00	2.71
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	21.27	30.80	7.15	2.75	0.00	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	51.74	38.57	3.76	6.58	0.94	0.00	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	59.26	71.84	7.27	4.19	0.28	0.00	0.56	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	44.12	36.29	4.94	6.98	0.17	0.34	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	54.81	39.24	4.80	2.98	0.00	0.17	0.00	0.33
paracentral gyrus, adult, pool1	10035-101E8	63.79	30.66	4.58	2.11	1.10	0.09	0.18	1.37
parietal cortex, adult, donor10258	10373-105G4	66.79	24.22	1.47	1.47	1.47	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	66.77	47.02	7.52	5.64	0.00	0.00	0.00	2.82
parietal lobe, adult, donor10252	10157-103A4	78.67	25.65	5.70	2.57	0.57	0.00	0.29	2.00
parietal lobe, adult, pool1	10034-101E7	56.04	25.47	4.67	1.67	0.26	0.09	0.09	1.76
parietal lobe, fetal, donor1	10072-101I9	89.22	97.95	6.79	6.79	0.97	0.00	0.00	9.70
parietal lobe, newborn, donor10223	10356-105E5	69.91	28.04	7.10	1.12	0.75	0.00	0.00	1.50
parotid gland, adult	10199-103F1	48.10	30.83	3.08	1.23	0.00	1.23	0.00	0.00
penis, adult	10200-103F2	59.62	31.15	6.45	2.69	0.00	0.54	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	92.60	89.81	6.69	4.65	1.49	0.56	0.37	2.42
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	34.53	33.22	3.64	2.04	0.00	0.15	0.00	0.44
pineal gland - adult, donor10196	10179-103C8	112.23	38.06	9.03	3.87	0.00	0.65	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	121.40	50.34	10.66	8.88	0.59	0.00	0.00	3.55
pineal gland, adult, donor10258	10377-105G8	81.52	43.27	5.64	5.02	0.63	0.00	0.63	1.88
pituitary gland - adult, donor10196	10180-103C9	163.91	69.81	9.11	3.04	0.00	1.01	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	155.83	74.53	11.47	6.78	3.13	0.00	0.00	2.08
pituitary gland, adult, donor10258	10378-105G9	94.49	59.59	3.40	1.70	0.85	0.85	0.85	1.70
placenta, adult, pool1	10021-101D3	77.72	40.96	4.41	4.62	0.86	0.11	0.11	1.51
plasma cell leukemia cell line:ARH-77	10840-111E3	45.69	40.79	4.37	3.71	0.26	0.13	0.13	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	71.75	33.15	20.70	2.80	0.31	0.00	0.00	0.62
pons, adult, pool1	10033-101E6	46.30	28.40	4.05	2.07	0.52	0.09	0.00	1.29
postcentral gyrus, adult, pool1	10032-101E5	58.76	27.20	4.10	1.13	0.61	0.00	0.09	1.66
promyelocytes/myelocytes PMC, donor1	12132-128D8	81.56	317.89	12.55	4.18	0.00	0.00	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	66.10	33.05	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	45.16	34.23	6.70	1.60	0.29	0.15	0.29	0.00
prostate cancer cell line:PC-3	10439-106E7	49.01	41.38	2.72	2.90	0.18	0.00	0.18	0.73
prostate, adult, pool1	10022-101D4	85.61	33.92	9.89	3.17	1.00	0.00	0.00	2.63
putamen, adult, donor10196	10176-103C5	83.57	30.22	9.21	3.54	0.24	0.24	0.47	0.71
putamen, adult, donor10252	10152-102I8	96.08	39.21	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	40.43	40.43	4.37	5.46	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	52.67	33.10	3.14	2.42	0.24	0.48	0.00	1.45
putamen, newborn, donor10223	10365-105F5	65.97	17.24	11.99	0.75	0.75	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	64.01	73.61	9.89	6.40	0.00	0.29	0.29	0.58
rectum, fetal, donor1	10067-101I4	104.32	73.72	8.35	11.13	0.00	0.00	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	30.95	19.08	2.12	1.48	0.00	0.00	0.21	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	57.99	33.97	4.97	7.04	0.83	0.41	0.00	1.24
retina, adult, pool1	10030-101E3	80.02	30.32	7.95	1.79	0.89	0.00	0.00	1.99
retinoblastoma cell line:Y79	10475-106I7	56.12	51.70	9.35	4.16	0.26	0.00	0.52	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	41.80	43.40	10.20	2.58	0.00	0.37	0.37	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	253.08	238.74	14.90	15.47	0.56	0.28	0.00	2.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	116.71	36.38	9.85	1.52	0.00	0.00	0.76	1.52
salivary acinar cells, donor1	11771-123I7	50.34	22.66	11.49	1.94	0.00	0.16	0.49	0.32
salivary acinar cells, donor2	11772-123I8	48.33	24.37	5.09	1.51	0.00	0.28	0.00	0.41
salivary acinar cells, donor3	11773-123I9	93.35	52.30	13.24	9.27	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	59.48	37.18	3.43	3.43	0.00	0.00	0.00	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	33.81	28.41	6.32	1.52	0.08	0.00	0.17	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	39.14	28.92	9.29	1.76	0.00	0.00	0.12	0.35
seminal vesicle, adult	10201-103F3	79.36	35.45	0.53	0.53	0.53	0.00	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	43.97	29.39	8.26	5.10	0.24	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	54.86	32.71	35.48	3.52	0.75	0.00	0.25	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	48.17	35.12	5.02	2.01	0.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	43.25	36.80	4.16	2.55	0.00	0.13	0.13	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	39.68	55.04	3.87	4.75	0.22	0.00	0.00	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	33.93	49.55	6.06	2.58	0.00	0.00	0.26	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	95.05	82.99	22.70	13.48	0.00	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	84.56	76.52	28.19	11.15	0.48	0.12	0.00	0.72
skeletal muscle, fetal, donor1	10066-101I3	33.17	38.19	2.01	4.02	0.00	0.00	2.01	0.00
skin, adult, donor1	10074-102A2	74.64	33.93	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	66.28	44.82	6.31	6.94	1.26	0.00	0.00	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	63.04	56.70	14.34	6.00	0.33	0.00	0.67	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	80.38	61.47	18.91	6.62	0.00	0.32	0.95	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	58.79	7.71	2.70	0.39	2.31	0.19	0.19	2.70
small cell lung carcinoma cell line:LK-2	10541-107H1	108.95	113.73	10.38	4.78	0.33	0.00	0.00	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	73.83	34.74	3.06	4.83	0.64	0.48	0.16	2.41
small cell lung carcinoma cell line:WA-hT	10562-108A4	89.13	96.76	10.02	9.59	0.00	0.00	0.22	0.44
small intestine, adult, pool1	10024-101D6	76.80	59.96	4.42	2.27	0.72	0.00	0.00	0.48
small intestine, fetal, donor1	10064-101I1	63.39	50.86	2.70	4.18	0.74	0.00	0.00	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	34.36	27.70	4.62	2.56	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	69.01	24.29	10.08	1.55	1.29	0.26	0.00	1.29
somatostatinoma cell line:QGP-1	10781-110G7	57.09	49.85	5.09	5.09	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	74.10	38.54	9.41	4.59	1.38	0.23	0.46	1.84
spinal cord, adult, donor10252	10159-103A6	66.24	33.12	16.95	4.73	1.18	0.00	0.00	2.37
spinal cord, adult, donor10258	10369-105F9	85.09	26.29	6.92	2.77	0.69	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	63.42	37.81	3.05	2.44	0.61	0.00	0.00	3.05
spinal cord, newborn, donor10223	10359-105E8	70.72	34.90	15.61	5.51	0.46	0.00	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	50.18	27.63	5.82	2.99	0.00	0.00	0.15	0.90
spleen, adult, pool1	10025-101D7	85.79	45.60	4.52	3.08	0.55	0.11	0.11	0.88
spleen, fetal, pool1	10044-101F8	77.07	37.90	6.28	2.38	0.40	0.08	0.08	1.59
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	25.36	19.36	3.42	1.04	0.10	0.00	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	82.22	82.79	17.47	6.65	0.00	0.38	0.00	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	66.75	40.54	10.83	4.19	0.00	0.70	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	44.18	57.47	5.86	7.43	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	48.85	66.18	3.38	4.50	0.68	0.00	0.11	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	34.31	26.69	2.54	2.54	0.00	0.00	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	89.27	47.81	5.92	3.38	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	112.14	60.87	5.34	2.14	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	73.49	38.74	3.42	2.28	0.57	0.00	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	108.55	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	66.05	25.34	8.72	4.15	0.62	0.21	0.21	1.25
substantia nigra, adult, donor10258	10371-105G2	54.83	37.24	2.59	4.66	0.52	0.00	0.00	2.07
substantia nigra, newborn, donor10223	10358-105E7	42.39	29.68	11.31	3.53	2.12	0.00	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	64.42	49.75	8.48	2.75	0.23	0.23	0.00	0.69
temporal lobe, adult, pool1	10031-101E4	49.17	21.53	2.63	1.36	0.85	0.08	0.08	1.19
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	105.42	60.54	6.41	3.56	4.27	0.00	0.00	6.41
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	95.38	44.39	3.52	1.76	2.64	1.32	0.00	7.03
tenocyte, donor1	11763-123H8	62.49	18.15	35.26	1.75	0.35	1.40	0.70	1.05
tenocyte, donor2	11765-123I1	50.74	18.31	14.12	2.29	0.76	0.00	0.38	0.76
tenocyte, donor3	11768-123I4	47.82	12.23	5.56	0.74	0.00	0.37	0.37	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	91.10	84.30	0.34	7.14	0.17	0.68	0.17	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	33.14	33.60	11.56	2.16	0.31	0.00	0.00	0.15
teratocarcinoma cell line:PA-1	10807-111A6	63.70	63.23	9.45	6.97	0.15	0.15	0.00	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	40.62	51.29	4.70	4.57	0.13	0.00	0.25	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	55.59	50.68	2.27	9.83	0.76	0.00	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	20.72	27.16	0.87	5.02	0.11	0.11	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	32.24	49.51	4.23	8.14	0.33	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	63.99	54.97	9.88	4.51	0.97	0.11	0.11	2.04
testis, adult, pool2	10096-102C6	50.52	63.60	3.16	9.47	1.35	0.45	0.90	1.80
thalamus - adult, donor10196	10168-103B6	96.05	43.06	11.04	4.42	1.10	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	67.98	35.16	6.72	4.06	0.31	0.16	0.00	2.50
thalamus, adult, donor10258, tech_rep1	10370-105G1	55.43	43.11	0.00	1.54	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	28.66	19.60	2.80	0.99	0.66	0.00	0.16	0.33
thalamus, newborn, donor10223	10366-105F6	44.87	17.83	8.63	2.88	0.00	0.00	0.00	0.58
throat, adult	10209-103G2	56.43	33.71	3.75	2.50	1.00	0.25	0.25	0.75
throat, fetal, donor1	10061-101H7	72.22	51.80	6.09	3.35	0.61	0.00	0.30	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	52.27	35.37	6.16	0.99	0.99	0.00	0.00	1.59
thymus, adult, pool1	10027-101D9	107.57	109.26	6.06	4.08	0.40	0.10	0.00	0.40
thymus, fetal, pool1	10043-101F7	121.15	88.84	18.18	4.57	0.42	0.31	0.21	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	37.10	34.44	3.46	2.79	0.13	0.00	0.00	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	30.31	31.43	1.68	2.93	0.56	0.00	0.14	0.56
thyroid, adult, pool1	10028-101E1	85.66	62.80	8.30	5.32	1.31	0.19	0.28	1.68
thyroid, fetal, donor1	10060-101H6	65.39	52.73	8.70	5.01	1.05	0.00	0.00	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	89.31	46.19	6.16	0.00	3.08	0.00	3.08	0.00
tongue, adult	10203-103F5	50.93	32.10	4.88	3.02	0.47	0.23	0.00	1.63
tongue, fetal, donor1	10059-101H5	55.17	46.11	4.34	3.55	0.39	0.39	0.00	0.39
tonsil, adult, pool1	10047-101G2	109.79	57.70	7.31	1.90	0.40	0.00	0.10	0.90
trachea, adult, pool1	10029-101E2	72.39	39.59	16.20	2.62	0.90	0.00	0.08	1.55
trachea, fetal, donor1	10058-101H4	71.17	41.93	9.23	7.31	0.00	0.00	0.00	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	43.22	27.28	5.67	0.71	0.35	0.00	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	59.27	59.68	14.89	5.07	0.30	0.00	0.00	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	84.45	65.50	19.59	5.17	0.00	0.47	0.31	0.31
tridermal teratoma cell line:HGRT	10694-109G1	157.91	60.88	30.44	11.42	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	28.87	35.05	3.81	3.81	0.00	0.08	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	56.34	22.95	8.35	0.00	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	90.94	38.39	4.10	3.07	1.02	0.34	0.17	5.29
uterus, fetal, donor1	10055-101H1	74.74	30.72	6.66	6.14	1.02	0.00	0.00	3.07
vagina, adult	10204-103F6	75.61	29.73	5.82	8.40	0.65	0.00	0.00	1.94
vein, adult	10191-103E2	81.54	43.18	5.04	1.97	0.00	0.44	0.22	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	31.51	32.31	3.20	0.53	0.27	0.27	0.00	0.27